<?xml version="1.0" encoding="utf-8"?>
<XML>
<JOURNAL>
<YEAR>2023</YEAR>
<VOL>27</VOL>
<NO>3</NO>
<MOSALSAL>0</MOSALSAL>
<PAGE_NO>330</PAGE_NO>


<ARTICLES>

	<ARTICLE> 
		<TitleF>An overview of animal models induced by glucocorticoids</TitleF>
		<TitleE></TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Glucocorticoids are widely employed for treating various disorders, but their administration is associated with multiple adverse effects. To study and understand these side effects, preclinical animal models have been developed. Experimental models that replicate essential aspects of human diseases offer valuable tools for assessing potential therapeutic agents and elucidating molecular and cellular pathways in a controlled environment. In this review, we provide an overview of various animal models in which glucocorticoids have been utilized to induce humanlike disorders across different body systems. These disorders encompass hypertension, skin atrophy, hair loss, insulin resistance, dyslipidemia, gastric mucosal damage, growth retardation, muscle atrophy, osteoporosis, osteonecrosis, depression-like behavior, glaucoma, and cataracts.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>211</FPAGE>
			<TPAGE>233</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2022/07/31
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1401/5/9
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2022/12/3
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1401/9/12
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>Azadeh</Name>
				<MidName></MidName>
				<Family>Mesripour</Family>
				<NameE>Azadeh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Mesripour</FamilyE>
				<Organizations>
				<Organization>Department of Pharmacology and Toxicology, Isfahan Pharmaceutical Sciences Research Center, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>a_mesripour@pharm.mui.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Mansooreh</Name>
				<MidName></MidName>
				<Family>Asghari-Varzaneh</Family>
				<NameE>Mansooreh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Asghari-Varzaneh</FamilyE>
				<Organizations>
				<Organization>Department of Pharmacology and Toxicology, Isfahan Pharmaceutical Sciences Research Center, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>mnfa2asghari@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Leila</Name>
				<MidName></MidName>
				<Family>Safaeian</Family>
				<NameE>Leila</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Safaeian</FamilyE>
				<Organizations>
				<Organization>Department of Pharmacology and Toxicology, Isfahan Pharmaceutical Sciences Research Center, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>leila_safaeian@pharm.mui.ac.ir</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Animal Experimentation</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Glucocorticoid</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Mice</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Model</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Rat</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>Agarwal S, Mirzoeva S, Readhead B, Dudley JT, Budunova I. PI3K inhibitors protect against glucocorticoid-induced skin atrophy. EBioMedicine 2019; 41:526-37.##Alan IS, Alan B. Side effects of glucocorticoids. In: Malangu N, editor. Pharmacokinetics and Adverse Effects of Drugs – Mechanisms and Risks Factors. IntechOpen 2018; 23: 93-115.##Alev K, Arved V, Maire A, Ando P, Priit P, Priit K, et al. Glucocorticoid-induced changes in rat skeletal muscle biomechanical and viscoelastic properties: Aspects of aging. J Manipulative Physiol Ther 2018; 41: 19-24.##Amin SS, Sachdeva S. Alopecia areata: A review. J Saudi Soc Dermatol Dermatol Surg 2013; 17: 37-45.##Anacker C, Zunszain PA, Carvalho LA, Pariante CM. The glucocorticoid receptor: pivot of depression and of antidepressant treatment? Psychoneuroendocrinology 2011; 36: 415-25.##Anagnos A, Ruffi RL, Kaminski H. Endocrine myopathies. Neurol Clin 1997; 15: 673-696.##Arnaldi G, Scandali VM, Trementino L, Cardinaletti M, Appolloni G, Boscaro M. Pathophysiology of dyslipidemia in Cushing’s syndrome. Neuroendocrinology 2010; 92: 86-90.##Aschenbach JR, Kristensen NB, Donkin SS, Hammon HM, Penner GB. Gluconeogenesis in dairy cows: the secret of making sweet milk from sour dough. IUBMB life 2010; 62: 869-77.##Bandyopadhyay U, Biswas K, Bandyopadhyay D, Ganguly C, Banerjee R. Dexamethasone makes the gastric mucosa susceptible to ulceration by inhibiting prostaglandin synthetase and peroxidase-two important gastroprotective enzymes. Mol Cell Biochem 1999; 202: 31-6.##Baofeng L, Zhi Y, Bei C, Guolin M, Qingshui Y, Jian L. Characterization of a rabbit osteoporosis model induced by ovariectomy and glucocorticoid. Acta Orthop 2010; 81: 396-401.##Baron J, Huang Z, Oerter KE, Bacher JD, Cutler GB. Dexamethasone acts locally to inhibit longitudinal bone growth in rabbits. Am J Physiol Cell Physiol 1992; 263: E489-92.##Baschant U, Henneicke H, Hofbauer LC, Rauner M. Sclerostin Blockade—A dual mode of action after all? J Bone Miner Res 2016; 31: 1787-90.##Basting T, Lazartigues E. DOCA-salt hypertension: an update. Curr Hypertens Rep 2017; 19: 1-8.##Beaupere C, Liboz A, Fève B, Blondeau B, Guillemain G. Molecular mechanisms of glucocorticoid-induced insulin resistance. Int J Mol Sci 2021; 22: 1-30.##Bekler H, Uygur AM, Gökçe A, Beyzadeoğlu T. The effect of steroid use on the pathogenesis of avascular necrosis of the femoral head: an animal model. Acta Orthop Traumatol Turc 2007; 41: 58-63.##Bitto A, Burnett B, Polito F, Levy R, Marini H, Di Stefano V, et al. Genistein aglycone reverses glucocorticoid-induced osteoporosis and increases bone breaking strength in rats: a comparative study with alendronate. Br J Pharmacol 2009; 156: 1287–95.##A Bouhenni R, Dunmire J, Sewell A, Edward DP. Animal models of glaucoma. J Biotechnol Biomed 2012; 2012:692609.##Boksenbaum M, Mendelson CG. Aseptic necrosis of the femoral head associated with steroid therapy. JAMA 1963; 184: 262-5.##Brown ES, Woolston DJ, Frol A, Bobadilla L, Khan DA, Hanczyc M, et al. Hippocampal volume, spectroscopy, cognition, and mood in patients receiving corticosteroid therapy. Biol Psychiatry 2004; 55: 538-45.##Bucala R, Callati M, Manabe S, Cotlier E, Cerami A. Glucocorticoid-lens protein adducts in experimentally induced steroid cataracts. Exp Eye Res 1985; 40: 853-63.##Buchman AL. Side effects of corticosteroid therapy. J Clin Gastroenterol 2001; 33: 289-94.##Burén J, Lai YC, Lundgren M, Eriksson JW, Jensen J. Insulin action and signaling in fat and muscle from dexamethasone-treated rats. Arch Biochem Biophys 2008; 474: 91-101.##Campbell JE, Peckett AJ, D’souza AM, Hawke TJ, Riddell MC. Adipogenic and lipolytic effects of chronic glucocorticoid exposure. Am J Physiol - Cell Physiol 2011; 300: C198-209.##Chrysis D, Ritzen EM, Sävendahl L. Growth retardation induced by dexamethasone is associated with increased apoptosis of the growth plate chondrocytes. J Endocrinol 2003; 176: 331-7.##Cicala MV, Mantero F. Hypertension in Cushing’s syndrome: from pathogenesis to treatment. Neuroendocrinology 2010; 92: 44-9.##Cumming RG, Mitchell P, Leeder SR. Use of inhaled corticosteroids and the risk of cataract. New Engl J Med USE 1997; 37: 8-14.##Dalle Carbonare L, Bertoldo F, Valenti MT, Zordan S, Sella S, Fassina A, et al. Risedronate prevents the loss of microarchitecture in glucocorticoid-induced osteoporosis in rats. J Endocrinol Invest 2007; 30: 739-46.##Dardevet D, Sornet C, Taillandier D, Savary I, Attaix D, Grizard J. Sensitivity and protein turnover response to glucocorticoids are different in skeletal muscle from adult and old rats. Lack of regulation of the ubiquitin-proteasome proteolytic pathway in aging. J Clin Invest 1995; 96: 2113-9.##Delforno C, Holt PJ, Marks R. Corticosteroid effect on epidermal cell size. Br J Dermatol 1978; 98: 619-23.##Djurhuus CB, Gravholt CH, Nielsen S, Pedersen SB, Møller N, Schmitz O. Additive effects of cortisol and growth hormone on regional and systemic lipolysis in humans. Am J Physiol - Endocrinol Metab 2004; 286: E488-94.##Drescher W, Weigert K.P, Bunger M.H, Ingerslev J, Bunger C, Hansen E.S. Femoral head blood flow reduction and hypercoagulability under 24 h megadose steroid treatment in pigs. J Orthop Res 2004; 22: 501–8.##Dubey H, Singh A, Patole AM, Tenpe CR. Antihypertensive effect of allicin in dexamethasone-induced hypertensive rats. Integr Med Res 2017 Mar; 6: 60-5.##Dunford EC, Riddell MC. The metabolic implications of glucocorticoids in a high-fat diet setting and the counter-effects of exercise. Metabolites 2016; 6: 44.##Eason JM, Dodd SL, Powers SK, Martin AD. Detrimental effects of short-term glucocorticoid use on the rat diaphragm. Phys Ther 2000; 80: 160-7.##Fawzy SA, Ahmed NA, Eldin Elshafie MD, Radwan SH. Effect of curcumin versus hyaluronic acid on glucocorticoid induced skin atrophy and subsequent skin abrasions in rats. Egypt J Histol 2019; 42: 35-50.##Fernandes C, McKittrick CR, File SE, McEwen BS. Decreased 5-HT1A and increased 5-HT2A receptor binding after chronic corticosterone associated with a behavioural indication of depression but not anxiety. Psychoneuroendocrinology 1997; 22: 477-91.##Filaretova L, Morozova O, Bagaeva T, Podvigina T. From gastroprotective to proulcerogenic action of glucocorticoids on the gastric mucosa. J Physiol Pharmacol 2009; 60: 79-86.##Filaretova L. Glucocorticoids are gastroprotective under physiologic conditions. Ther. Adv. Chronic Dis 2011; 2: 333-42.##Filep JG, Hermán F, Földes-Filep É, Schneider F, Braquet P. Dexamethasone-induced gastric mucosal damage in the rat: possible role of platelet-activating factor. Br J Pharmacol 1992; 105: 912-8.##Garlick PJ, Maltin CA, Baillie AGS, Delday MI &#38; Grubb DA (1989) Fiber-type composition of nine rat muscles. 11. Relationship to protein turnover Am J Physiol 1989; 257, E828-32.##Geer EB, Islam J, Buettner C. Mechanisms of glucocorticoid-induced insulin resistance: Focus on adipose tissue function and lipid metabolism. Endocrinol Metab Clin North Am 2014; 43: 75-102.##Goulding A, Gold E. Effects of chronic prednisolone treatment on bone resorption and bone composition in intact and ovariectomized rats and in ovariectomized rats receiving β-estradiol. Endocrinology 1988; 122: 482-7.##Gupta A, Gupta Y. Glucocorticoid-induced myopathy: Pathophysiology, diagnosis, and treatment. Indian J Endocrinol Metab 2013; 17: 913.##Harris JE, Gruber L. The electrolyte and water balance of the lens. Exp Eye Res 1962; 1: 372-84.##Hazra A, Pyszczynski NA, DuBois DC, Almon RR, Jusko WJ. Modeling of corticosteroid effects on hepatic low-density lipoprotein receptors and plasma lipid dynamics in rats. Pharm Res 2008; 25: 769-80.##Hedya S, Hawila N, Abdin A, Maaly AE. Luteolin attenuates dexamethasone-induced skeletal muscle atrophy in male albino rats. Med J Cairo Univ 2019; 87: 3365-74.##Henderson AK, Webster CR. Disruption of the gastric mucosal barrier in dogs. Compend Contin Educ Pract Vet 2006; 28: 340-56.##Henn F, Vollmayr B, Sartorius A. Mechanisms of depression: the role of neurogenesis. Drug Discov Today Dis Mech 2004; 1: 407-11.##Hernandez-Denlinger LM, Edelman JL. A surrogate model of intravitreal glucocorticoid-induced cataract and ocular hypertension. Investig Ophthalmol Vis Sci 2008; 49:1658.##Herrmann M, Henneicke H, Street J, Modzelewski J, Kalak R, Buttgereit F, et al. The challenge of continuous exogenous glucocorticoid administration in mice. Steroids 2009;74: 245–9.##Isidori AM, Graziadio C, Paragliola RM, Cozzolino A, Ambrogio AG, Colao A, et al. The hypertension of Cushing’s syndrome: controversies in the pathophysiology and focus on cardiovascular complications. J Hypertens 2015; 33: 44.##James ER. The etiology of steroid cataract. J Ocul Pharmacol Ther 2007; 23: 403-20.##Jiang Y, Gou H, Wang S, Zhu J, Tian S, Yu L. Effect of pulsed electromagnetic field on bone formation and lipid metabolism of glucocorticoid-induced osteoporosis rats through canonical Wnt signaling pathway Evid Based Complementary Altern Med 2016; 2016: 1–13.##Jobling AI, Augusteyn RC. What causes steroid cataracts? A review of steroid-induced posterior subcapsular cataracts. Clin Exp Optom 2002; 85: 61-75.##Kajiyama Y, Iijima Y, Chiba S, Furuta M, Ninomiya M, Izumi A, et al. Prednisolone causes anxiety-and depression-like behaviors and altered expression of apoptotic genes in mice hippocampus. Prog Neuro-Psychopharmacol Biol Psychiatry 2010; 34:159-65.##Kappe C, Fransson L, Wolbert P, Ortsäter H. Glucocorticoids suppress GLP-1 secretion: possible contribution to their diabetogenic effects. Clin Sci 2015; 129: 405-14.##Kemer S, Karademir F, Aydemir G, Kucukodaci Z, Pirgon O, Genc FA, et al. Effects of Inhaled Corticosteroids on the Growth Plates of Infant Rats. Fetal Pediatr Pathol 2015; 34: 223-32.##Kennedy B, Elayan H, Ziegler M.G. Glucocorticoid induction of epinephrine synthesizing enzyme in rat skeletal muscle and insulin resistance. J Clin Invest 1993; 92, 303-307.##Kennedy CC, Papaioannou A, Adachi JD. Glucocorticoid-induced osteoporosis. Women’s Heal 2006; 2: 65-74.##Kerachian MA, Séguin C, Harvey EJ. Glucocorticoids in osteonecrosis of the femoral head: a new understanding of the mechanisms of action. J Steroid Biochem Mol Biol 2009; 114:121-8.##Kohlmann Jr OS, Ribeiro AB, Marson OD, Saragoca MA, Ramos OL. Methylprednisolone-induced hypertension. Role for the autonomic and renin angiotensin systems. Hypertension 1981; 3: II-107.##Kolbe L, Kligman AM, Schreiner V, Stoudemayer T. Corticosteroid-induced atrophy and barrier impairment measured by non-invasive methods in human skin. Ski Res Technol 2001; 7: 73-7.##Konno S. Hydroxyl radical formation in skeletal muscle of rats with glucocorticoid-induced myopathy. Neurochem Res 2005; 30, 669-75.##Kosano H, Nishigori H. Steroid-induced cataract: other than in the whole animal system, in the lens culture system, androgens, estrogens and progestins as well as glucocorticoids produce a loss of transparency of the lens. Dev. Ophthalmol. 2002; 35:161-8.##Krishnan V, Nestler EJ. Animal models of depression: molecular perspectives. Curr Top Behav Neurosci 2011; 121-47. https://doi.org/ 10.1007/7854_2010_108##Kugelberg M, Shafiei K, Ohlsson C, Sävendahl L, Zetterström C. Glucocorticoid eye drops inhibit growth in the newborn rabbit. Acta Paediatrica 2005; 94: 1096–101.##Kumai T, Asoh K, Tateishi T, Tanaka M, Watanabe M, Shimizu H, et al. Involvement of tyrosine hydroxylase up regulation in dexamethasone-induced hypertension of rats. Life Sci 2000; 67:1993-9.##Kumar S., Shah S., Deutsch E.R., Tang H.M., Danias J. Triamcinolone acetonide decreases outflow facility in C57BL/6 mouse eyes. Invest Ophthalmol Vis Sci 2013; 54:1280–7.##Kumar VRS, Inamdar MN, Viswanatha GL. Protective effect of lemongrass oil against dexamethasone induced hyperlipidemia in rats: Possible role of decreased lecithin cholesterol acetyl transferase activity. Asian Pac J Trop Med 2011; 4: 658-60.##Kwack MH, Lee JH, Seo CH, Kim JC, Kim MK, Sung YK. Dickkopf-1 is involved in dexamethasone-mediated hair follicle regression. Exp Dermatol 2017; 26: 952-4.##Lambillotte C, Gilon P, Henquin JC. Direct glucocorticoid inhibition of insulin secretion: An in vitro study of dexamethasone effects in mouse islets. J Clin Invest 1997; 99: 414-23.##Lee MJ, Lee JS, Lee MC. Apoptosis of skeletal muscle on steroid-induced myopathy in rats. J Korean Med Sci 2001; 16: 467-74.##Lee SE, Lee EY, Kang SJ, Lee SH. 11Β-hydroxysteroid dehydrogenase type 1 inhibition attenuates the adverse effects of glucocorticoids on dermal papilla cells. Yonsei Med J 2017; 58: 1204-10.##Levine RA, McGuire RF. Corticosteroid-induced pancreatitis: A case report demonstrating recurrence with rechallenge. Am J Gastroenterol 1988; 83: 1161-4.##Li M, Fraser T, Wang J, Whitworth JA. Dexamethasone-induced hypertension in the rat: effects of L-arginine. Clin Exp Pharmacol Physiol 1997; 24: 730-2.##Li X, Jin L, Cui Q, Wang GJ, Balian G. Steroid effects on osteogenesis through mesenchymal cell gene expression. Osteoporos Int 2005; 16: 101-8.##Lin HY, Lee YT, Chan YW, Tse G. Animal models for the study of primary and secondary hypertension in humans. Biomed Rep 2016; 5: 653-9.##Lin T, Liu J, Yang S, Liu X, Feng X, Fu D. Relation between the development of osteoporosis and osteonecrosis following glucocorticoid in a rabbit model. Indian J Orthop 2016; 50: 406.##Luo JC, Shin VY, Liu ESL, So WHL, Ye YN, Chang FY, et al. Non-ulcerogenic dose of dexamethasone delays gastric ulcer healing in rats. J Pharmacol Exp Ther 2003; 307: 692-8.##Ma L, Shen Q, Yang S, Xie X, Xiao Q, Yu C, et al. Effect of chronic corticosterone-induced depression on circadian rhythms and age-related phenotypes in mice. Acta Biochim Biophys Sin 2018; 50: 1236-46.##Maddineni P, Kasetti RB, Patel PD, Millar JC, Kiehlbauch C, Clark AF, et al. CNS axonal degeneration and transport deficits at the optic nerve head precede structural and functional loss of retinal ganglion cells in a mouse model of glaucoma. Mol Neurodegener 2020; 15: 1-20.##Mahendran P, Devi CSS. Effect of Garcinia cambogia extract on lipids and lipoprotein composition in dexamthesone administered rats. Indian J Physiol Pharmacol 2001; 45: 345-50##Martínez BB, Pereira AC, Muzetti JH, Telles FD, Mundim FG, Teixeira MA. Experimental model of glucocorticoid-induced insulin resistance. Acta Cir Bras 2016; 31:645-9.##Maubec E, Laouénan C, Deschamps L, Nguyen VT, Scheer-Senyarich I, Wackenheim-Jacobs AC, et al. Topical mineralocorticoid receptor blockade limits glucocorticoid-induced epidermal atrophy in human skin. J Invest Dermatol 2015; 135: 1781-9.##McLaughlin F, Mackintosh J, Hayes BP, McLaren A, Uings IJ, Salmon P, et al. Glucocorticoid-induced osteopenia in the mouse as assessed by histomorphometry, microcomputed tomography, and biochemical markers. Bone 2002; 30: 924–30.##Mesripour A, Alhimma F, Hajhashemi V. The effect of vitamin B6 on dexamethasone-induced depression in mice model of despair. Nutr Neurosci 2019; 22: 744-9.##Mesripour A, Karimi Z, Minaiyan M. Creatine and α-lipoic acid improved depressive behavior induced by interferon-α in mice: Malondialdehyde level remained unchanged. J Rep Pharm Sci 2021; 10: 124.##Mesripour A, Rakhshankhah P. A synbiotic mixture ameliorates depressive behavior induced by dexamethasone or water avoidance stress in a mouse model. Turkish J Pharm Sci 2021; 18: 21.##Miller D, Tijerina ML, Mayman C. In vitro production of steroids cataract in bovine lens: Part I: Measurement of optical changes. Acta Ophthalmol 1979; 57: 1101-6.##Mirshahpanah P, Döcke WD, Merbold U, Asadullah K, Röse L, Schäcke H, et al. Superior nuclear receptor selectivity and therapeutic index of methylprednisolone aceponate versus mometasone furoate. Exp Dermatol 2007; 16:753-61.##Motta K, Barbosa AM, Bobinski F, Boschero AC, Rafacho A. JNK and IKKβ phosphorylation is reduced by glucocorticoids in adipose tissue from insulin-resistant rats. J Steroid Biochem Mol Biol 2015; 145: 1-12.##Naber D, Sand P, Heigl B. Psychopathological and neuropsychological effects of 8-days’ corticosteroid treatment. A prospective study. Psychoneuroendocrinology 1996; 21: 25-31.##Nagai K, Sasaki H, Kojima M, Sasaki K. An alternative method of steroid-induced lens opacification in brown norway rat eyes applying systemic pulse administration. Ophthalmic Res 2004; 36: 231-6.##Nagornev VA, Zubzhitskii YN, Pigarevskii P V, Ivanovskii Y V. Effect of hydrocortisone on the development of experimental atherosclerosis in rabbits. Bull Exp Biol Med 1980; 90: 1344-6.##Nakamoto H, Suzuki H, Kageyama Y, Ohishi A, Murakami M, Naitoh M, et al. Characterization of alterations of hemodynamics and neuroendocrine hormones in dexamethasone induced hypertension in dogs. Clin Exp Hypertens A 1991; 13: 587-606.##Newton M, Cooper BT. Benign intracranial hypertension during prednisolone treatment for inflammatory bowel disease. Gut 1994; 35: 423-5.##Niculet E, Bobeica C, Tatu AL. Glucocorticoid-induced skin atrophy: The old and the new. Clin Cosmet Investig Dermatol 2020; 13: 1041-50.##Nishigori H, Lee JW, Yamauchi Y, Maruyama K, Iwatsuru M. Analysis of glucose levels during glucocorticoid-induced cataract formation in chick embryos. Investig Ophthalmol Vis Sci 1987; 28: 168-74.##Noh KK, Chung KW, Choi YJ, Park MH, Jang EJ, Park CH, et.al. β–Hydroxy β–methylbutyrate improves dexamethasone-induced muscle atrophy by modulating the muscle degradation pathway in SD rat. PLoS One 2014; 9: e102947.##Notman MT. Incest: Understanding and Treatment. Am J Psychiatry 1984; 141: 457-8.##Ohnaka K, Tanabe M, Kawate H, Nawata H, Takayanagi R. Glucocorticoid suppresses the canonical Wnt signal in cultured human osteoblasts. Biochem Biophys Res Commun 2005; 329: 177-81.##Ong SL, Zhang Y, Whitworth JA. Mechanisms of dexamethasone-induced hypertension. Curr Hypertens Rev 2009; 5: 61-74.##Okuno T, Suzuki H, Saruta T. Dexamethasone hypertension in rats. Clin Exp Hypertens 1981; 3: 1075-86.##Olefsky JM, Johnson J, Liu F, Jen P, Reaven GM. The effects of acute and chronic dexamethasone administration on insulin binding to isolated rat hepatocytes and adipocytes. Metabolism 1975; 24: 517-27.##Ortoft G, Grønbaek H, Oxlund H. Growth hormone administration can improve growth in glucocorticoid-injected rats without affecting the lymphocytopenic effect of the glucocorticoid. Growth Horm IGF Res 1998a; 8: 251–64.##Ortoft G, Oxlund H &#38; Andreassen TT. Administration of a glucocorticoid with depot effect counteracts the stimulating effect of growth hormone on cancellous and cortical bone of the vertebral body in rats. Calcif Tissue Int 1998b; 63: 14-21.##Overby DR, Clark AF, Texas UN, Science H. Animal Models of Glucocorticoid-Induced Glaucoma. Exp Eye Res 2016; 141: 15-22.##Overby DR, Bertrand J, Tektas OY, Boussommier-Calleja A, Schicht M, Ethier CR, et al. Ultrastructural changes associated with dexamethasone-induced ocular hypertension in mice. Invest Ophthalmol. Vis Sci 2014; 55: 4922-33.##Owen HC, Ahmed SF, Farquharson C. Chondrocyte p21 (WAF1/CIP1) expression is increased by dexamethasone but does not contribute to dexamethasone-induced growth retardation in vivo. Calcif Tissue Int 2009; 85: 326-34.##Pasieka AM, Rafacho A. Impact of glucocorticoid excess on glucose tolerance: Clinical and preclinical evidence. Metabolites 2016; 6: 24.##Patel GC, Millar JC, Clark AF. Glucocorticoid receptor transactivation is required for glucocorticoid-induced ocular hypertension and glaucoma. Investig Ophthalmol Vis Sci 2019; 60: 1967-78.##Paus R, Handjiski B, Czarnetzki BM, Eichmüller S. A murine model for inducing and manipulating hair follicle regression (catagen): Effects of dexamethasone and cyclosporin A. J Invest Dermatol 1994; 103: 143-7.##Pescosolido N, Miccheli A, Manetti C, Iannetti GD, Feher J, Cavallotti C. Metabolic changes in rabbit lens induced by treatment with dexamethasone. Ophthalmic Res 2001; 33: 68-74.##Qin L, Zhang G, Sheng H, Yeung KW, Yeung HY, Chan CW, et al. Multiple bioimaging modalities in evaluation of an experimental osteonecrosis induced by a combination of lipopolysaccharide and methylprednisolone. Bone 2006; 39: 863-71.##Qin Y, Lam S, Yam GH, Choy KW, Liu DT, Chiu TY, et al. A rabbit model of age-dependant ocular hypertensive response to topical corticosteroids. Acta Ophthalmol 2010; 90: 559-63.##Rafacho A, Gonçalves-Neto LM, Santos-Silva JC, Alonso-Magdalena P, Merino B, Taboga SR, et al. Pancreatic alpha-cell dysfunction contributes to the disruption of glucose homeostasis and compensatory insulin hypersecretion in glucocorticoid-treated rats. PLoS One 2014; 9: e93531.##Raghunathan VK, Morgan JT, Park SA, Weber D, Phinney BS, Murphy CJ, et al. Dexamethasone stiffens trabecular meshwork, trabecular meshwork cells, and matrix. Investig Ophthalmol Vis Sci 2015; 56: 4447-59.##Ridder S, Chourbaji S, Hellweg R, Urani A, Zacher C, Schmid W, et al. Mice with genetically altered glucocorticoid receptor expression show altered sensitivity for stress-induced depressive reactions. J Neurosci 2005; 25: 6243-50.##Rooman R, Koster J, Bloemen R, Gresnigt R. The effect of dexamethasone on body and organ growth of normal and The effect of dexamethasone on body and organ growth of normal and IGF-II-transgenic mice. J Endocrinol 2017; 163: 543-54.##Røpke MA, Alonso C, Jung S, Norsgaard H, Richter C, Darvin ME, et al. Effects of glucocorticoids on stratum corneum lipids and function in human skin—A detailed lipidomic analysis. J Dermatol Sci 2017; 88: 330-8.##Ross IL, Marais AD. The influence of glucocorticoids on lipid and lipoprotein metabolism and atherosclerosis. South African Med J 2014; 104: 671-4.##Rozsíval P, Hampl R, Obenberger J, Stárka L, Řehák S. Aqueous humour and plasma cortisol levels in glaucoma and cataract patients. Curr Eye Res 1981; 1: 391-6.##Ruzzin J, Wagman AS, Jensen J. Glucocorticoid-induced insulin resistance in skeletal muscles: Defects in insulin signalling and the effects of a selective glycogen synthase kinase-3 inhibitor. Diabetologia 2005; 48: 2119-30.##Safaeian L, Ghasemi-Dehkordi N, Javanmard SH, Namvar H. Antihypertensive and antioxidant effects of a hydroalcoholic extract obtained from aerial parts of Otostegia persica (Burm.) Boiss. Res Pharm Sci 2015; 10: 192-9.##Safaeian L, Zolfaghari B, Karimi S, Talebi A, Ghazvini MA. The effects of hydroalcoholic extract of Allium elburzense Wendelbo bulb on dexamethasone-induced dyslipidemia, hyperglycemia, and oxidative stress in rats. Res Pharm Sci 2018; 13: 22-9.##Safaeian L, Zolfaghari B, Assarzadeh N, Ghadirkhomi A. Antioxidant and anti-hyperlipidemic effects of bark extract of Pinus eldarica in dexamethasone-induced dyslipidemic rats. J Adv Med Biomed Res 2019; 27 (125): 49-56.##Sakoda H, Ogihara T, Anai M, Funaki M, Inukai K, Katagiri H, et al. Dexamethasone-induced insulin resistance in 3T3-L1 adipocytes is due to inhibition of glucose transport rather than insulin signal transduction. Diabetes 2000; 49: 1700-8.##Sato AY, Cregor M, Delgado-Calle J, Condon KW, Allen MR, Peacock M, et al. Protection from glucocorticoid-induced osteoporosis by anti-catabolic signaling in the absence of sost/sclerostin. J Bone Miner Res 2016; 31 :1791-802.##Sato A, Suzuki H, Iwaita Y, Nakazato Y, Kato H, Saruta T. Potentiation of inositol trisphosphate production by dexamethasone. Hypertension 1992; 19: 109-15.##Sawaguchi K, Nakamura Y, Nakamura Y, Sakai H, Sawaguchi S. Myocilin gene expression in the trabecular meshwork of rats in a steroid-induced ocular hypertension model. Ophthalmic Res 2005; 37, 235-42.##Schakman O, Gilson H, Thissen JP. Mechanisms of glucocorticoid-induced myopathy. J. Endocrinol 2008; 197: 1-10.##Schellenberg S, Mettler M, Gentilini F, Portmann R, Glaus TM, Reusch CE. The effects of hydrocortisone on systemic arterial blood pressure and urinary protein excretion in dogs. J Vet Intern Med 2008; 22: 273-81.##Schoepe S, Schäcke H, May E, Asadullah K. Glucocorticoid therapy-induced skin atrophy. Exp Dermatol 2006; 15: 406-20.##Schoepe S, Vonk R, Schäcke H, Zollner TM, Asadullah K, Röse L. Shortened treatment duration of glucocorticoid-induced skin atrophy in rats. Exp Dermatol 2011; 20: 853-5.##Sheng HH, Zhang GG, Cheung WHWH, Chan CWCW, Wang YXYX, Lee KMKM, et al. Elevated adipogenesis of marrow mesenchymal stem cells during early steroid-associated osteonecrosis development. J Orthop Surg Res 2007; 2: 1-7.##Sheng H, Zhang G, Wang YX, Yeung DK, Griffith JF, Leung KS, Qin L. Functional perfusion MRI predicts later occurrence of steroid-associated osteonecrosis: An experimental study in rabbits. J Orthop Res 2009; 27: 742-7.##Shpilberg Y, Beaudry JL, D’Souza A, Campbell JE, Peckett A, Riddell MC. A rodent model of rapid-onset diabetes induced by glucocorticoids and high-fat feeding. Dis Models Mech 2012; 5: 671-80.##Shue HM, Lee JYY, Chai CY, Kuo KW. Depletion of stratum corneum intercellular lipid lamellae and barrier function abnormalities after long-term topical corticosteroids. Br J Dermatol 1997; 136: 884-90.##Silvestrini G, Ballanti P, Patacchioli FR, Mocetti P, Di Grezia R, et al. Evaluation of apoptosis and the glucocorticoid receptor in the cartilage growth plate and metaphyseal bone cells of rats after high-dose treatment with corticosterone. Bone 2000; 26: 33–42.##Skalka HW, Prchal JT. Effect of corticosteroids on cataract formation in man. Investig Ophthalmol Vis Sci 1980; 19: 50.##Skoner DP, Szefler SJ, Welch M, Walton-Bowen K, Cruz-Rivera M, Smith JA. Longitudinal growth in infants and young children treated with budesonide inhalation suspension for persistent asthma. J Allergy Clin Immunol 2000; 105: 259-68.##Smink JJ, Koster JG, Gresnigt MG, Rooman R, Koedam JA, Van Buul-Offers SC. IGF and IGF-binding protein expression in the growth plate of normal, dexamethasone-treated and human IGF-II transgenic mice. J Endocrinol 2002; 175: 143-53.##Smith JG, Wehr RF, Chalker DK. Corticosteroid-induced cutaneous atrophy and telangiectasia: experimental production associated with weight loss in rats. Arch Dermatol 1976; 112:1115-7.##Song Z, Gao H, Liu H, Sun X. Metabolomics of rabbit aqueous humor after administration of glucocorticosteroid. Curr Eye Res 2011; 36: 563-70.##Sousa N, Lukoyanov N V, Madeira MD, Almeida OFX, Paula-Barbosa MM. Erratum: Reorganization of the morphology of hippocampal neuritis and synapses after stress-induced damage correlates with behavioral improvement. Neuroscience 2000; 101: 483.##Staels B, Van Toi A, Chan L, Verhoeven G, Auwerx J. Variable effects of different corticosteroids on plasma lipids, apolipoproteins, and hepatic apolipoprotein mRNA levels in rats. Arterioscler Thromb Vasc Biol 1991; 11: 760-9.##Stamer WD, Clark AF. The many faces of the trabecular meshwork cell. Exp. Eye Res 2017;158: 112-23.##Stenn KS, Paus R, Dutton T, Sarba B. Glucocorticoid effect on hair growth initiation: A reconsideration. Skin Pharmacol Physiol 1993; 6: 125-34.##Sun X, Feng M, Lu L, Zhao Z, Bao X, Deng K, et al. Lipid abnormalities in patients with cushing’s disease and its relationship with impaired glucose metabolism. Front Endocrinol (Lausanne) 2021; 11: 1-9.##Takano-Murakami R, Tokunaga K, Kondo N, Ito T, Kitahara H, Ito M, et al. Glucocorticoid inhibits bone regeneration after osteonecrosis of the femoral head in aged female rats. Tohoku J Exp Med 2009; 217: 51-8.##Tarkkanen A, Esilä R, Liesmaa M. Experimental cataracts following long-term administration of corticosteroids. Acta Ophthalmol 1966; 44: 665-8.##Tata DA, Anderson BJ. The effects of chronic glucocorticoid exposure on dendritic length, synapse numbers and glial volume in animal models: Implications for hippocampal volume reductions in depression. Physiol Behav 2010; 99: 186-93.##Timmermans S, Souffriau J, Libert C. A general introduction to glucocorticoid biology. Front Immunol 2019; 10: 1545.##Tulipano G, Taylor JE, Halem HA, Datta R, Dong JZ, Culler MD, et al. Glucocorticoid inhibition of growth in rats: partial reversal with the full-length ghrelin analog BIM-28125. Pituitary 2007; 10: 267–74.##Turno-Krecicka A, Grzybowski A, Misiuk-Hojło M, Patryn E, Czajor K, Nita M. Ocular changes induced by drugs commonly used in dermatology. Clin Dermatol 2016; 34: 129-37.##Turner AS. Animal models of osteoporosis-necessity and limitations. Eur Cell Mater 2001; 1: 66-81.##Wallace JL. Glucocorticoid-induced gastric mucosal damage: inhibition of leukotriene, but not prostaglandin biosynthesis. Prostaglandins 1987; 34: 311-23.##Wang GJ, Cui Q, Balian G. The pathogenesis and prevention of steroid-induced osteonecrosis. Clin Orthop Relat Res 2000: 295–310.##Wang JC, Gray NE, Kuo T, Harris CA. Regulation of triglyceride metabolism by glucocorticoid receptor. Cell Biosci 2012; 2: 1-9.##Ward WE, Donovan SM, Atkinson SA. Dexamethasone-induced abnormalities in growth and bone metabolism in piglets are partially attenuated by growth hormone with no synergistic effect of insulin-like growth factor-I. Pediatr Res 1998; 44: 215–221.##Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts end osteocytes by glucocorticoids potential mechanisms of their deleterious effects on bone. J Clin Invest 1998; 102: 274-82.##Weinstein RS. Glucocorticoid-induced bone disease. N Engl J Med 2011; 365: 62-70.##Whitlock NA, McKnight B, Corcoran KN, Rodriguez LA, Rice DS. Increased intraocular pressure in mice treated with dexamethasone. Invest Ophthalmol Vis Sci 2010; 51: 6496–6503.##Whitworth JA, Schyvens CG, Zhang Y, Mangos GJ, Kelly JJ. Glucocorticoid-induced hypertension: From mouse to man. Clin Exp Pharmacol Physiol 2001; 28: 993-6.##Wimalawansa SJ, Simmons DJ. Prevention of corticosteroid-induced bone loss with alendronate. Proc Soc Exp Biol Med 1998; 217: 162–7.##Wood CL, Soucek O, Wong SC, Zaman F, Farquharson C, Savendahl L, et al. Animal models to explore the effects of glucocorticoids on skeletal growth and structure. J Endocrinol 2018; 236: R69-91.##Wood DC, Contaxis I, Sweet D, Smith JC, Van Dolah J. Response of rabbits to corticosteroids. I. Influence on growth, intraocular pressure and lens transparency. Am J Ophthalmol 1967; 63: 841-9.##Wróbel A, Serefko A, Wlaź P, Poleszak E. The effect of imipramine, ketamine, and zinc in the mouse model of depression. Metab Brain Dis 2015; 30: 1379-86.##Xie XH, Wang XL, Yang HL, Zhao DW, Qin L. Steroid-associated osteonecrosis: Epidemiology, pathophysiology, animal model, prevention, and potential treatments (an overview). J Orthop Transl 2015; 3: 58-70.##Xu J, Gong H, Lu S, Deasey MJ, Cui Q. Animal models of steroid-induced osteonecrosis of the femoral head—a comprehensive research review up to 2018. Int Orthop 2018; 42: 1729-37.##Yamamoto D, Maki T, Herningtyas EH, Ikeshita N, Shibahara H, Sugiyama Y, et al. Branched-chain amino acids protect against dexamethasone-nduced soleus muscle atrophy in rats. Muscle &#38; Nerve: Muscle Nerve 2010; 41: 819-27.##Yamamoto T, Hirano K, Tsutsui H, Sugioka Y, Sueishi K. Corticosteroid enhances the experimental induction of osteonecrosis in rabbits with Shwartzman reaction. Clin Orthop Relat Res 1995; 1: 235-43.##Yamamoto T, Irisa T, Sugioka Y, Sueishi K, Yamamoto T, Irisa T, et al. Effects of pulse methylprednisolone on bone and marrow tissues. Corticosteroid-induced osteonecrosis in rabbits. Arthritis Rheumatol 1997; 40: 2055-64.##Yang L, Boyd K, Kaste SC, Kamdem L, Rahija RJ, Relling MV. A mouse model for glucocorticoid-induced osteonecrosis: effect of a steroid holiday. J Orthop Res 2009; 27: 169–75.##Yao W, Cheng Z, Pham A, Busse C, Zimmermann EA, Ritchie RO, Lane NE. Glucocorticoid-induced bone loss can be reversed by the actions of PTH and Risedronate on different pathways for bone formation and mineralization. Arthritis Rheumatol 2008a; 58: 3485.##Yao W, Cheng Z, Busse C, Pham A, Nakamura MC, Lane NE. Glucocorticoid excess in mice results in early activation of osteoclastogenesis and adipogenesis and prolonged suppression of osteogenesis: A longitudinal study of gene expression in bone tissue from glucocorticoid- treated mice. Arthritis Rheumatol 2008b; 58: 1674–86.##Yokote Y, Kimura E, Kimura M, Kozono Y. Biomechanical analysis of combined treatment of high calcium and bisphosphonate in tibia of steroid-treated growing-phase rats. Dent Mater J 2008; 27: 647–53.##Yongtao Z, Kunzheng W, Jingjing Z, Hu S, Jianqiang K, Ruiyu L, et al. Glucocorticoids activate the local renin–angiotensin system in bone: possible mechanism for glucocorticoid-induced osteoporosis. Endocrine 2014; 47: 598–608.##Young JM, Yoxall BE, Wagner BM. Corticosteroid induced dermal atrophy in the rat. J Invest Dermatol 1977; 69: 458-62.##Zhang G, Qin L, Sheng H, Wang XL, Wang YX, Yeung DKW, et al. A novel semisynthesized small molecule icaritin reduces incidence of steroid-associated osteonecrosis with inhibition of both thrombosis and lipid-deposition in a dose-dependent manner. Bone 2009; 44: 345-56.##Zheng LZ, Wang JL, Kong L, Huang L, Tian L, Pang QQ, et al. Steroid-associated osteonecrosis animal model in rats. J Orthop Transl 2018; 13: 13-24.##Zode GS, Kuehn MH, Nishimura DY, Searby CC, Mohan K, Grozdanic SD, et al. Corrigendum: Reduction of ER stress via a chemical chaperone prevents disease phenotypes in a mouse model of primary open angle glaucoma. J Clin Invest 2014; 125: 3303.##Zode GS, Sharma AB, Lin X, Searby CC, Bugge K, Kim GH, et al. Ocular-specific ER stress reduction rescues glaucoma in murine glucocorticoid-induced glaucoma. J Clin Invest 2011; 124: 1956-65.## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>Smart hospitals worldwide: a systematic review</TitleF>
		<TitleE></TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>The term &#8220;Smart hospital&#8221; is a highly comprehensive concept and it has not received the attention it deserves among researchers, as it is more than using a smart tool in a hospital. This study was designed to conduct a review of smart hospitals. In this systematic review, 808 studies were identified using keywords through searches on PubMed, Science Direct, Embase, Scopus and IEEE databases. After applying the inclusion and exclusion criteria (705 based on abstracts and titles and 35 after reading full texts) and removing duplicates (43), 25 studies were included in this review. Geographically, of the majority of the articles were from Asia (60%). The highest number of publications was observed in 2012 and 2020. A multidisciplinary team was involved in 72% of the research, and 68% were conducted in more than one research center. Most articles have been published in Q1 quality journals (48%), and high-income countries accounted for the largest percentage (56). Notably, 32% of these studies focused on patient care. RFID technology was the most used technology, featured in 66.67% of the studies, which primarily centered on the implementation of smart hospitals. It should be noted that development or implementation of a smart device in a hospital should not be equated with the implementation of a smart hospital and it is far beyond that.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>234</FPAGE>
			<TPAGE>243</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2022/07/312022/08/22
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1401/5/31
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2022/12/32022/11/27
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1401/9/6
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>Marjan</Name>
				<MidName></MidName>
				<Family>Rasoulian Kasrineh</Family>
				<NameE>Marjan</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Rasoulian Kasrineh</FamilyE>
				<Organizations>
				<Organization>Department of Medical Informatics, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>rasouliankm2@mums.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Nahid</Name>
				<MidName></MidName>
				<Family>Sharifzadeh</Family>
				<NameE>Nahid</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Sharifzadeh</FamilyE>
				<Organizations>
				<Organization>Department of Medical Informatics, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>sharifzadehn9@mums.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Moslem</Name>
				<MidName></MidName>
				<Family>taheri soodejani</Family>
				<NameE>Moslem</NameE>
				<MidNameE></MidNameE>
				<FamilyE>taheri soodejani</FamilyE>
				<Organizations>
				<Organization>Center for Healthcare Data Modeling, Departments of Biostatistics and Epidemiology, School of Public Health, Shahid Sadoughi University of Medical  Sciences, Yazd, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>moslem.taheri2009@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Seyyed Mohammad</Name>
				<MidName></MidName>
				<Family>Tabatabaei</Family>
				<NameE>Seyyed Mohammad</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Tabatabaei</FamilyE>
				<Organizations>
				<Organization>Department of Medical Informatics, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>TabatabaeiMH@mums.ac.ir</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Smart Hospital</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Digital Hospital</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Smart Device</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Smart Health</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>Arksey H, O’Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol 2005; 8: 19-32.##Berwick DM, Nolan TW, Whittington J. The triple aim: care, health, and cost. Health affairs 2008; 27: 759-769.##Bucci S, Schwannauer M, Berry N. The digital revolution and its impact on mental health care. Psychol Psychother 2019; 92: 277-297.##Bygstad B, Øvrelid E. Architectural alignment of process innovation and digital infrastructure in a high-tech hospital. Eur J Inf Syst 2020; 29: 220-237.##De Almeida LFF, Pereira LAM, Sodré AC, Mendes LL, Rodrigues JJ, Rabelo RA, et al. Control networks and smart grid teleprotection: Key aspects, technologies, protocols, and case-studies. IEEE Access 2020; 8: 174049-174079.##Fischer GS, da Rosa Righi R, de Oliveira Ramos G, da Costa CA, Rodrigues JJ. ElHealth: Using Internet of Things and data prediction for elastic management of human resources in smart hospitals. Eng Appl Artif Intell 2020; 87: 103285.##Garg N. Technology in healthcare: vision of smart hospitals. Handbook of Research on Engineering, Business, and Healthcare Applications of Data Science and Analytics: IGI Global, 2021: 346-362.##Ghebreyesus TA. Urgent health challenges for the next decade. World Health Organization 2020; 13.##He T, Li S. A comparative study of digital informal learning: The effects of digital competence and technology expectancy. Br J Educ Technol 2019; 50: 1744-1758.##Hoehe MR, Thibaut F. Going digital: how technology use may influence human brains and behavior. Dialogues Clin Neurosci 2022; 22(2): 93–97.##Holzinger A, Röcker C, Ziefle M. From smart health to smart hospitals. Smart Health: Open Problems and Future Challenges 2015: 1-20.##Howarth A, Quesada J, Silva J, Judycki S, Mills PR. The impact of digital health interventions on health-related outcomes in the workplace: a systematic review. Digital health 2018; 4: 2055207618770861.##Ilin I, Iliyaschenko O, Konradi A. Business model for smart hospital health organization. SHS Web of Conferences 2018; 44: 00041.##Ilyashenko O, Ilin I, Kurapeev D. Smart Hospital concept and its implementation capabilities based on the incentive extension. SHS Web of Conferences 2018; 44: 00040.##Kharbanda V, Bohlin N, Sehlstedt U, Treutiger J. Building the Smart Hospital Agenda. 2017.##Krick T, Huter K, Domhoff D, Schmidt A, Rothgang H, Wolf-Ostermann K. Digital technology and nursing care: a scoping review on acceptance, effectiveness and efficiency studies of informal and formal care technologies. BMC Health Serv Res 2019; 19: 1-15.##Liu B, He K, Zhi G. The impact of big data and artificial intelligence on the future medical model. Journal of Life and Environmental Sciences (PeerJ) 2018; 39: 1-4.##Manyisa ZM, van Aswegen EJ. Factors affecting working conditions in public hospitals: A literature review. Int J Afr Nurs Sci 2017; 6: 28-38.##Mathews SC, McShea MJ, Hanley CL, Ravitz A, Labrique A B, Cohen A B. Digital health: a path to validation. NPJ Digit Med 2019; 2: 38.##Mitchell M, Kan L. Digital technology and the future of health systems. Health Syst Reform [Internet]. 2019; 5 (2): 113-20. Journal.##Moro Visconti R, Martiniello L. Smart hospitals and patient-centered governance. Moro Visconti, R., &#38; Martiniello, L.(2019). Smart hospitals and patient-centered governance. Corp Ownersh Control 2019; 16.##Moro Visconti R, Morea D. Healthcare digitalization and pay-for-performance incentives in smart hospital project financing. Int J Environ Res Public Health 2020; 17: 2318.##Nordo AH, Levaux HP, Becnel LB, Galvez J, Rao P, Stem K, et al. Use of EHRs data for clinical research: historical progress and current applications. Learn Health Syst 2019; 3: e10076.##Oueida S, Aloqaily M, Ionescu S. A smart healthcare reward model for resource allocation in smart city. Multimed Tools Appl 2019; 78: 24573-24594.##Peters MD, Godfrey C M, McInerney P, Soares C B, Khalil H, Parker D. The Joanna Briggs Institute reviewers’ manual 2015: methodology for JBI scoping reviews. 2015.##Redhead CS. The Health Information Technology for Economic and Clinical Health (HITECH) Act. Journal 2009.##Ricciardi W. Assessing the impact of digital transformation of health services: Opinion by the Expert Panel on Effective Ways of Investing in Health (EXPH). Eur J Public Health 2019; 29: ckz185. 769.##Risling T. Educating the nurses of 2025: Technology trends of the next decade. Nurse Educ Pract 2017; 22: 89-92.##Rizwan P. Design and development of low investment smart hospital using internet of things through innovative approaches. Biomed Res (0970-938X) 2017; 28.##Serbanati LD. Health digital state and Smart EHR systems. Inform Med Unlocked 2020; 21: 100494.##Tabatabaei SM, Kasrineh MR, Sharifzadeh N, Soodejani MT. COVID-19: an Alarm to Move Faster towards “Smart Hospitals”. Online J Public Health Inform 2021; 13.##Thakare V, Khire G. Role of emerging technology for building smart hospital information system. Procedia Econom Bus Adm 2014; 11: 583-588.##Tian S, Yang W, Le Grange JM, Wang P, Huang W, Ye Z. Smart healthcare: making medical care more intelligent. J Glob Health 2019; 3: 62-65.##Uslu BÇ, Okay E, Dursun E. Analysis of factors affecting IoT-based smart hospital design. J Cloud Comput 2020; 9: 1-23.##Vecchia GD, Gallo L, Esposito M, Coronato A. An infrastructure for smart hospitals. Multimed Tools Appl 2012; 59: 341-362.## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>The effect of photoperiodic stress on anxiety-like behaviors, learning, memory, locomotor activity and memory consolidation in rats</TitleF>
		<TitleE></TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Introduction: Light-dark cycles regulate the body&#8217;s physiological activity; hence, marked changes in these cycles could lead to conditions with impaired brain functions and disrupted moods (e.g., stress). Therefore, this study compared the impact of stress due to various photoperiodic durations on anxiety-like behavior, learning, memory, locomotor activity and memory consolidation in rats.
Methods: Thirty-five male rats were divided into five groups with different light(L)-dark(D) cycles: L20/D4, L16/D8, L12/D12 (control), L8/D16 and L4/D20 groups. After14 days, the elevated plus-maze (EPM) and passive avoidance (PA) tests were performed to assess the anxiety-like behaviors and brain functions.
Results: The percentage of spent time, number of entries to the open arm of the EPM test and the entrance latency to the dark room of the PA test decreased significantly in the L20/D4 and L4/D20 groups; however, the reduction of latency to enter the dark room was particularly significant in the L20/D4 group. In addition, there were significant differences between the initial latency and latency after one day (as learning) in all experimental groups. The total dark stay time increased significantly in different photoperiods.
Conclusion: An abnormal light-dark length could disrupt certain brain functions, such as learning, memory, locomotor activity, memory consolidation and anxiety-like behavioral responses at different levels in a time-independent manner. The light-dark length (both minimum and especially the maximum day length) led to increased learning impairment and memory deficits, as well as worsened anxiety-like behaviors. The memory consolidation was also disrupted with various photoperiods.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>244</FPAGE>
			<TPAGE>253</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2022/07/312022/08/222022/07/3
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1401/4/12
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2022/12/32022/11/272022/09/18
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1401/6/27
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>Kowsar</Name>
				<MidName></MidName>
				<Family>Salehifard</Family>
				<NameE>Kowsar</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Salehifard</FamilyE>
				<Organizations>
				<Organization>Department of Physiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>kowsar.9619@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Maryam</Name>
				<MidName></MidName>
				<Family>Radahmadi</Family>
				<NameE>Maryam</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Radahmadi</FamilyE>
				<Organizations>
				<Organization>Department of Physiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>m_radahmadi@med.mui.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Parham</Name>
				<MidName></MidName>
				<Family>Reisi</Family>
				<NameE>Parham</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Reisi</FamilyE>
				<Organizations>
				<Organization>Department of Physiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>reisi@med.mui.ac.ir</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Photoperiod</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>learning</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>memory</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>anxiety</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>rat</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>Arziqni N, Hadi S. The Effect of Long Photoperiod on The Visuospatial Working Memory in Wistar Rats (Rattus norvegicus)[Pengaruh Pencahayaan Panjang Terhadap Memori Kerja Visuospasial Tikus Wistar (Rattus norvegicus)]. Jurnal Biologi Indonesia 2021; 17: 127-134.##Atger F, Mauvoisin D, Weger B, Gobet C, Gachon F. Regulation of mammalian physiology by interconnected circadian and feeding rhythms. Frontiers in endocrinology 2017; 8: 42.##Barnes A K, Smith S B, Datta S J P O. Beyond emotional and spatial processes: cognitive dysfunction in a depressive phenotype produced by long photoperiod exposure. 2017; 12: e0170032.##Beauvalet J C, Pilz L K, Hidalgo M P L, Elisabetsky E. Is chronodisruption a vulnerability factor to stress? Behavioural Brain Research 2019; 359: 333-341.##Bellivier F, Geoffroy P A, Etain B, Scott J. Sleep- and circadian rhythm-associated pathways as therapeutic targets in bipolar disorder. Expert Opin Ther Targets 2015; 19: 747-63.##Boerngen-Lacerda R, Souza-Formigoni M L O. Does the increase in locomotion induced by ethanol indicate its stimulant or anxiolytic properties? Pharmacology Biochemistry and Behavior 2000; 67: 225-232.##Boonstra R, McColl C J. Contrasting stress response of male arctic ground squirrels and red squirrels. Journal of Experimental Zoology 2000; 286: 390-404.##Breuner C, Wingfield J. Rapid behavioral response to corticosterone varies with photoperiod and dose. Hormones and behavior 2000; 37: 23-30.##Dastgerdi H H, Radahmadi M, Reisi P. Comparative study of the protective effects of crocin and exercise on long-term potentiation of CA1 in rats under chronic unpredictable stress. Life sciences 2020; 256: 118018.##Do Nascimento E B, Dierschnabel A L, de Macêdo Medeiros A, Suchecki D, Silva R H, Ribeiro A M. Memory impairment induced by different types of prolonged stress is dependent on the phase of the estrous cycle in female rats. Hormones and Behavior 2019; 115: 104563.##Emmer K M, Russart K L, Walker II W H, Nelson R J, DeVries A C. Effects of light at night on laboratory animals and research outcomes. Behavioral neuroscience 2018; 132: 302.##Farhud D, Aryan Z. Circadian Rhythm, Lifestyle and Health: A Narrative Review. Iran journal of public health 2018; 47: 1068-1076.##Fonken L K, Finy M S, Walton J C, Weil Z M, Workman J L, Ross J, et al. Influence of light at night on murine anxiety-and depressive-like responses. Behavioural brain research 2009; 205: 349-354.##Gu B, Tan Q, Zhao S. The association between occupational stress and psychosomatic wellbeing among Chinese nurses: a cross-sectional survey. Medicine 2019; 98.##Hadad-Ophir O, Albrecht A, Stork O, Richter-Levin G. Amygdala activation and GABAergic gene expression in hippocampal sub-regions at the interplay of stress and spatial learning. Frontiers in behavioral neuroscience 2014; 8: 3.##Hafez M H, Gad S B. Zinc Oxide Nanoparticles Effect on Oxidative Status, Brain Activity, Anxiety-Like Behavior and Memory in Adult and Aged Male Rats. Pakistan Veterinary Journal 2018; 38.##Hosseini-Sharifabad A, Mofid M R, Moradmand M, Keimasi M. The Effect of Omega-lycotoxin on the Cognitive Impairment Induced by Kainic Acid in Rats. Iranian Journal of Toxicology 2021; 15: 49-56.##Hou Y, Wang Y, Song S, Zuo Y, Zhang H, Bai C, et al. Long-term variable photoperiod exposure impairs the mPFC and induces anxiety and depression-like behavior in male wistar rats. Experimental Neurology 2022; 347: 113908.##Kalantarzadeh E, Radahmadi M, Reisi P. Effects of different dark chocolate diets on memory functions and brain corticosterone levels in rats under chronic stress. Physiology and Pharmacology 2020; 24.##Kaliyaperumal D, Elango Y, Alagesan M, Santhanakrishanan I. effects of Sleep Deprivation on the Cognitive Performance of Nurses Working in Shift. Journal of Clinical and Diagnostic Research 2017; 11.##Klyubin I, Ondrejcak T, Hu N-W, Rowan M J. Glucocorticoids, synaptic plasticity and Alzheimer's disease. Current Opinion in Endocrine and Metabolic Research 2022: 100365.##Knight P, Chellian R, Wilson R, Behnood-Rod A, Panunzio S, Bruijnzeel A W. Sex differences in the elevated plus-maze test and large open field test in adult Wistar rats. Pharmacology Biochemistry and Behavior 2021; 204: 173168.##Landgraf D, McCarthy M J, Welsh D K. Circadian Clock and Stress Interactions in the Molecular Biology of Psychiatric Disorders. Current Psychiatry Reports 2014; 16: 483.##Leach G, Adidharm W, Yan L. Depression-Like Responses Induced by Daytime Light Deficiency in the Diurnal Grass Rat (Arvicanthis niloticus). PLoS ONE 2013; 8.##Lee B, Sur B, Oh S. Neuroprotective effect of Korean red ginseng against single prolonged stress-induced memory impairments and inflammation in the rat brain associated with BDNF expression. Journal of Ginseng Research 2022; 46: 435-443.##Lee Y, Wisor J P. Multi-Modal Regulation of Circadian Physiology by Interactive Features of Biological Clocks. Biology 2021; 11: 21.##Logan R W, McClung C A. Rhythms of life: circadian disruption and brain disorders across the lifespan. Nature Reviews Neuroscience 2019; 20: 49-65.##López-Olmeda J F, Zhao H, Reischl M, Pylatiuk C, Lucon-Xiccato T, Loosli F, et al. Long photoperiod impairs learning in male but not female medaka. Iscience 2021; 24: 102784.##Lu Q, Zhang Y, Zhao C, Zhang H, Pu Y, Yin L. Copper induces oxidative stress and apoptosis of hippocampal neuron via pCREB/BDNF/and Nrf2/HO‐1/NQO1 pathway. Journal of Applied Toxicology 2022; 42: 694-705.##Lunsford-Avery J R, Gonçalves B d S B, Brietzke E, Bressan R A, Gadelha A, Auerbach R P, et al. Adolescents at clinical-high risk for psychosis: Circadian rhythm disturbances predict worsened prognosis at 1-year follow-up. Schizophrenia Research 2017; 189: 37-42.##Ma L, Li Y. The effect of depression on sleep quality and the circadian rhythm of ambulatory blood pressure in older patients with hypertension. Journal of Clinical Neuroscience 2017; 39: 49-52.##McEwen B S. Glucocorticoids, depression, and mood disorders: structural remodeling in the brain. Metabolism 2005; 54: 20-23.##Ouanes S, Popp J. High cortisol and the risk of dementia and Alzheimer's disease: a review of the literature. Frontiers in aging neuroscience 2019; 11: 43.##Patki G, Solanki N, Atrooz F, Allam F, Salim S. Depression, anxiety-like behavior and memory impairment are associated with increased oxidative stress and inflammation in a rat model of social stress. Brain research 2013; 1539: 73-86.##Phan T X, Malkani R G. Sleep and circadian rhythm disruption and stress intersect in Alzheimer's disease. Neurobiology of Stress 2019; 10: 100133.##Pyter L M, Reader B F, Nelson R J. Short photoperiods impair spatial learning and alter hippocampal dendritic morphology in adult male white-footed mice (Peromyscus leucopus). Journal of Neuroscience 2005a; 25: 4521-4526.##Pyter L M, Reader B F, Nelson R J. Short photoperiods impair spatial learning and alter hippocampal dendritic morphology in adult male white-footed mice (Peromyscus leucopus). J Neurosci 2005b; 25: 4521-6.##Radahmadi M, Alaei H, Sharifi M R, Hosseini N. Stress biomarker responses to different protocols of forced exercise in chronically stressed rats. Journal of bodywork movement therapies 2017; 21: 63-68.##Ranjbar H, Radahmadi M, Alaei H, Reisi P, Karimi S. The effect of basolateral amygdala nucleus lesion on memory under acute, mid and chronic stress in male rats. Turkish journal of medical sciences 2016; 46: 1915-1925.##Ruan W, Yuan X, Eltzschig H K. Circadian rhythm as a therapeutic target. Nature Reviews Drug Discovery 2021; 20: 287-307.##Russell G, Lightman S. The human stress response. Nature reviews endocrinology 2019; 15: 525-534.##Sestakova N, Puzserova A, Kluknavsky M, Bernatova I. Determination of motor activity and anxiety-related behaviour in rodents: methodological aspects and role of nitric oxide. Interdisciplinary toxicology 2013; 6: 126-135.##Silva A L, Fry W H, Sweeney C, Trainor B C. Effects of photoperiod and experience on aggressive behavior in female California mice. Behavioural brain research 2010; 208: 528-534.##Soler J E, Stumpfig M, Tang Y-P, Robison A J, Núñez A A, Yan L. Daytime light intensity modulates spatial learning and hippocampal plasticity in female Nile grass rats (Arvicanthis niloticus). Neuroscience 2019; 404: 175-183.##Stothard E R, McHill A W, Depner C M, Birks B R, Moehlman T M, Ritchie H K, et al. Circadian Entrainment to the Natural Light-Dark Cycle across Seasons and the Weekend. Current Biology 2017; 27: 508-513.##Subhadeep D, Srikumar B, Rao S, Kutty B M. Exposure to Short Photoperiod Regime Restores Spatial Cognition in Ventral Subicular Lesioned Rats: Potential Role of Hippocampal Plasticity, Glucocorticoid Receptors, and Neurogenesis. Molecular Neurobiology 2021; 58: 4437-4459.##Subhadeep D, Srikumar B N, Shankaranarayana Rao B S, Kutty B M. Short photoperiod restores ventral subicular lesion‐induced deficits in affective and socio‐cognitive behavior in male Wistar rats. Journal of Neuroscience Research 2020; 98: 1114-1136.##Tahara Y, Aoyama S, Shibata S. The mammalian circadian clock and its entrainment by stress and exercise. The Journal of Physiological Sciences 2016; 67.##Takahashi L. Olfactory systems and neural circuits that modulate predator odor fear. Frontiers in Behavioral Neuroscience 2014; 8.##Tamminga C A, Southcott S, Sacco C, Wagner A D, Ghose S. Glutamate dysfunction in hippocampus: relevance of dentate gyrus and CA3 signaling. Schizophrenia bulletin 2012; 38: 927-935.##Thangwong P, Jearjaroen P, Govitrapong P, Tocharus C, Tocharus J. Melatonin improves cognitive function by suppressing endoplasmic reticulum stress and promoting synaptic plasticity during chronic cerebral hypoperfusion in rats. Biochemical Pharmacology 2022; 198: 114980.##Valdés‐Tovar M, Estrada‐Reyes R, Solís‐Chagoyán H, Argueta J, Dorantes‐Barrón A M, Quero‐Chávez D, et al. Circadian modulation of neuroplasticity by melatonin: a target in the treatment of depression. British journal of pharmacology 2018; 175: 3200-3208.##Walton J C, Chen Z, Weil Z M, Pyter L M, Travers J B, Nelson R J. Photoperiod-mediated impairment of long-term potention and learning and memory in male white-footed mice. Neuroscience 2011a; 175: 127-32.##Walton J C, Chen Z, Weil Z M, Pyter L M, Travers J B, Nelson R J J N. Photoperiod-mediated impairment of long-term potention and learning and memory in male white-footed mice. 2011b; 175: 127-132.##Weiss I C, Di Iorio L, Feldon J, Domeney A M. Strain differences in the isolation-induced effects on prepulse inhibition of the acoustic startle response and on locomotor activity. Behavioral neuroscience 2000; 114: 364.##Workman J L, Manny N, Walton J C, Nelson R J. Short day lengths alter stress and depressive-like responses, and hippocampal morphology in Siberian hamsters. Horm Behav 2011; 60: 520-8.##Yang J, Hou C, Ma N, Liu J, Zhang Y, Zhou J, et al. Enriched environment treatment restores impaired hippocampal synaptic plasticity and cognitive deficits induced by prenatal chronic stress. Neurobiology of learning and memory 2007; 87: 257-263.##Youngstedt S D, Elliott J A, Kripke D F. Human circadian phase-response curves for exercise. The Journal of Physiology 2019; 597: 2253-2268.##Zelinski E L, Hong N S, McDonald R J J A c. Persistent impairments in hippocampal function following a brief series of photoperiod shifts in rats. 2014; 17: 127-141.##Zhang I. The Impact of Emotional Arousal on Amygdala Activity, Memory Consolidation, and Long-Term Potentiation in the Hippocampus. Journal of Student Research 2022; 11.##Zoeram S B, Salmani M E, Lashkarbolouki T, Goudarzi I. Hippocampal orexin receptor blocking prevented the stress induced social learning and memory deficits. Neurobiology of Learning and Memory 2019; 157: 12-23.## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>The effect of tempol, a potent synthetic antioxidant, on the limb teratogenicity in an experimental model of preeclampsia in rats</TitleF>
		<TitleE></TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Introduction: Preeclampsia is the principal cause of maternal morbidity and is characterized by hypertension, proteinuria, and edema. It is believed that oxidative stress plays an essential role in the pathophysiology of preeclampsia. This study was conducted to determine the effect of tempol on fetal limb hemorrhage, malformations, and oxidative stress in an N-nitro-L-arginine methyl ester (L-NAME)-induced preeclamptic rat model.
Methods: To induce preeclampsia, L-NAME (50 mg/kg/day, oral) was administered from day 11 of pregnancy to day 22. Four preeclamptic groups received L-NAME alone, L-NAME+tempol (20, 60, 180 mg/kg/day; L-NAME, L-T20, L-T60, L-T180 groups, respectively). The control group (normal pregnant) received only tap water, and the T60 group received tempol (60 mg/Kg) alone (without L-NAME). The concentration of 8-isoprostane in plasma and placenta, number and weight of the fetuses, and the limb defects were measured on the 22nd day of the pregnancy.
Results: L-NAME administration caused placental oxidative stress, limb defects and hemorrhage, and low fetal weight. Administration of tempol at 20 and 60 mg/kg/day reduced limb defects (10.5 and 7.2 percent versus 24.7 percent) and limb hemorrhage (14.5 and 9.5 percent versus 23 percent) induced by L-NAME. After administration of tempol (20 and 60 mg/kg), fetal weight increased (5.14&#177;0.08 and 5.44&#177;0.15 versus 4.27&#177; 0.11 g). Administration of tempol at the high dose (180 mg/kg/day) did not produce any significant effects on the measured parameters.
Conclusion: Tempol with certain doses improves fetal outcomes in an experimental rat model of preeclampsia. These may be the results of its antioxidant action.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>254</FPAGE>
			<TPAGE>260</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2022/07/312022/08/222022/07/32021/09/13
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1400/6/22
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2022/12/32022/11/272022/09/182022/08/27
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1401/6/5
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>Mohammadreza</Name>
				<MidName></MidName>
				<Family>Namavar</Family>
				<NameE>Mohammadreza</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Namavar</FamilyE>
				<Organizations>
				<Organization>Clinical Neurology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran; 2Histomorphometry and Stereology Research Center &#38; Department of anatomical Sciences, Shiraz</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>namavarm@sums.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>mohammad sharif</Name>
				<MidName></MidName>
				<Family>talebianpoor</Family>
				<NameE>mohammad sharif</NameE>
				<MidNameE></MidNameE>
				<FamilyE>talebianpoor</FamilyE>
				<Organizations>
				<Organization>Herbal Medicine Research Center, School of Medicine, Yasouj University of Medical Sciences, Yasouj, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>Taleb_84@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Somayeh</Name>
				<MidName></MidName>
				<Family>Nazari</Family>
				<NameE>Somayeh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Nazari</FamilyE>
				<Organizations>
				<Organization>Medicinal &#38; Natural Products Chemistry Research Center, Shiraz University of Medical Sciences, Shiraz, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>s.nazarii85@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Hossein</Name>
				<MidName></MidName>
				<Family>Mirkhani</Family>
				<NameE>Hossein</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Mirkhani</FamilyE>
				<Organizations>
				<Organization>Department of Pharmacology, Shiraz University of Medical Sciences, Shiraz, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>mirkhanh@sums.ac.ir</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Limb malformation</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>L-NAME</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Oxidative stress</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Preeclampsia</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Tempol</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>Altoama K, Mallem MY, Thorin C, Betti E, Desfontis JC. Effect of nebivolol treatment during pregnancy on the intrauterine fetal growth, mortality and pup postnatal development in the l-NAME-induced hypertensive rats. Eur J Pharmacol 2016; 791: 465-72.##Amaral TA, Ognibene DT, Carvalho LC, Rocha APM, Costa CA, Moura RS, Resende AC. Differential responses of mesenteric arterial bed to vasoactive substances in L-NAME-induced preeclampsia: Role of oxidative stress and endothelial dysfunction. Clin Exp Hypertens 2018; 40: 126-35.##Ardanaz NBW, Pagano PJ. Distinct hydrogen peroxide-induced constriction in multiple mouse arteries: potential influence of vascular polarization. Pharmacol Rep 2008; 60: 61-7.##Beckman JS KW. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol; 1996: 271, C1424-37.##Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-54.##Burton GJ, Jauniaux E. Placental oxidative stress: from miscarriage to preeclampsia. JSGI 2004;11: 342-52.##Cushen SC, Goulopoulou S. New models of pregnancy-associated hypertension. Am J Hypertens 2017; 30: 1053-62.##Fantel A, Stamps L, Tran T, Mackler B, Person R, Nekahi N. Role of free radicals in the limb teratogenicity of L-NAME (NG-nitro-L-arginine methyl ester): a new mechanistic model of vascular disruption. Teratology 1999; 60: 151-60.##Fantel AGPR. Further evidence for the role of free radicals in the limb teratogenicity of L-NAME. Teratology 2002; 66: 24-32.##García-Redondo ABBA, Beltrán AE, Alonso MJ, Simonsen U, Salaices M. Hypertension increases contractile responses to hydrogen peroxide in resistance arteries through increased thromboxane A2, Ca2+, and superoxide anion levels. J Pharmacol Exp Ther 2009; 328: 19-27.##Gregg AR, Schauer A, Shi O, Liu Z, Lee CG, O’Brien WE. Limb reduction defects in endothelial nitric oxide synthase-deficient mice Am J Physiol Heart Circ Physiol 1998; 275: H2319-24.##Gupta S, Agarwal A, Sharma RK. The role of placental oxidative stress and lipid peroxidation in preeclampsia. Obstet Gynecol Surv 2005; 60: 807-16.##Helmbrecht GD, Farhat MY, Lochbaum L, Brown HE, Yadgarova KT, Eglinton GS, Ramwell PW. L-arginine reverses the adverse pregnancy changes induced by nitric oxide synthase inhibition in the rat. Am J Obstet Gynecol 1996; 175: 800-5.##Makris SL, Solomon HM, Clark R, Shiota K, Barbellion S, Buschmann J, Hazelden KP. Terminology of developmental abnormalities in common laboratory mammals (version 2). Congenit Anom 2009; 49: 123-246.##Noris MPN, Remuzzi G. Mechanisms of disease: Pre-eclampsia. Nat Clin Pract Nephrol 2005: 1: 98-114.##Ornaghi S, Hsieh LS, Bordey A, Vergani P, Paidas MJ, van den Pol AN. Valnoctamide inhibits cytomegalovirus infection in developing brain and attenuates neurobehavioral dysfunctions and brain abnormalities J Neurosci 2017; 37: 6877-93.##Podjarny EBC, Losonczy G. Animal models of preeclampsia. Semin Perinatol 1999; 23: 2-13.##Podjarny E, Benchetrit S, Katz B, Green J, Bernheim J. Effect of methyldopa on renal function in rats with L-NAME-induced hypertension in pregnancy. Nephron 2001;88: 354-59.##Preti SC, Da Cunha V, Vassallo DV, Stefanon I. The superoxide dismutase mimetic, tempol, reduces the bioavailability of nitric oxide and does not alter l-name-induced hypertension in rats. Basic Clin Pharmacol Toxicol 2005; 97: 29-34.##Rafikova OSE, Tofovic SP. Renal and metabolic effects of tempol in obese ZSF1 rats--distinct role for superoxide and hydrogen peroxide in diabetic renal injury. Metabolism 2008; 57: 1434-44.##Ramos JGL, Sass N, Costa, SHM. Preeclampsia. Rev Bras Ginecol Obstet 2017; 39: 496-512.##Roggensack AM, Zhang Y, Davidge ST. Evidence for peroxynitrite formation in the vasculature of women with preeclampsia. Hypertension 1999; 33: 83-89.##Ryu SKR, Samuni A, Ornoy A. Nitroxide radicals protect cultured rat embryos and yolk sacs from diabetic-induced damage. Birth Defects Res A Clin Mol Teratol 2007; 79: 604-11.##Sedeek M, Gilbert JS, LaMarca BB, Sholook M, Chandler DL, Wang Y, Granger JP. Role of reactive oxygen species in hypertension produced by reduced uterine perfusion in pregnant rats. Am J Hypertens 2008; 21: 1152-56.##Talebianpoor MS, Mirkhani H.. The effect of tempol administration on the aortic contractile responses in rat preeclampsia model. ISRN pharmacol 2012; 2012.##Talebianpoor MS, Owji SM, Goharinia M, Mirkhani H. Effect of tempol, a synthetic antioxidant, on renal complications of L-NAME induced preeclampsia in rat. Physiol Pharmacol 2017; 21: 241-50.##Talebianpoor MS, Delaviz H, Rafei R, Mohannadi B, Sadeghi H, Mohammadi J, Rad P. Resveratrol attenuates fetal limb malformation and cardiac hypertrophy after preeclampsia induced by L-NAME in pregnant rats. J Pharm Sci Res 2018; 10: 361-4.##Tanir HM ST, Inal M Akyuz F, Uzuner K, Sivri E. Effect of quercetine and glutathione on the level of superoxide dismutase, catalase, malonyldialdehyde, blood pressure and neonatal outcome in a rat model of pre-eclampsia induced by NG-nitro-L-arginine-methyl ester. Eur J Obstet Gynecol Reprod Biol 2005; 118: 190-5.##Tenório MB, Ferreira RC, Moura FA, Bueno NB, de Oliveira ACM, Goulart MOF. Cross-Talk between Oxidative Stress and Inflammation in Preeclampsia. Oxid Med Cell Longev, 2019; 8238727.##Tiboni GM GF, Di Giulio C. The nitric oxide synthesis inhibitor Nomega-nitro-L-arginine methyl ester (L-NAME) causes limb defects in mouse fetuses: protective effect of acute hyperoxia. Pediatr Res 2003; 54: 69-76.## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>Toxicity assessment of a polyherbal drug on haematological parameters, brain and spleen histoarchitecture in exposed Wistar rats</TitleF>
		<TitleE></TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Introduction: We investigated the subchronic toxicity concerns of a polyherbal formulation (PHF; Dr Iguedo Goko Cleanser&#174;) on haematological indices, brain and spleen histomorphology in exposed Wistar rats of both sexes.
Methods: Thirty Wistar rats randomly allotted to six groups (5/group) were experimentally exposed to PHF via the oral route for 60 days as follows: control groups (1 and 4; given 5ml/kg distilled water); groups 2, 5 (476.24mg/kg) and 3, 6 (158.75mg/kg) body weight PHF, respectively. On 62nd day, animals were euthanized using carbon dioxide and sacrificed; spleen and brain tissues were evis-cerated, weighed and fixed in 10% buffered-formalin for histopathological assessment.
Results: Our results showed significant increase in platelet in all experimental rats relative to control. Low dosed (158.75mg/kg) male rats recorded a significant increase in WBC relative to control. Also increased were MCV and MCH in male rats. High dosed female rats had increased RBC and MCV. Neutrophils and lymphocyte differentials were respectively decreased and increased in experimental groups relative to control. Histopathology of the spleen and brain tissues revealed degrees of pathologies like abnormal cytostructure of lymphoid follicle, degenerated T-lymphocytes, numerous organic deposits, degenerating neural cells, proliferating astrocytes, widely scattered blood vessel amongst others.
Conclusion: Our findings revealed exposure-associated toxic effects of the quasi-drug formulation on blood parameters and histostructure of the spleen and brain. Findings suggest utmost caution on long-term use of the polyherbal formulation and avoidance whenever possible.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>261</FPAGE>
			<TPAGE>270</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2022/07/312022/08/222022/07/32021/09/132022/04/7
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1401/1/18
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2022/12/32022/11/272022/09/182022/08/272022/09/18
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1401/6/27
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>Godswill J.</Name>
				<MidName></MidName>
				<Family>Udom</Family>
				<NameE>Godswill J.</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Udom</FamilyE>
				<Organizations>
				<Organization>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Federal University Oye-Ekiti, PMB 373, Oye-Ekiti, Nigeria</Organization>
				</Organizations>
				<Countries>
				<Country>Nigeria</Country>
				</Countries>
				<EMAILS>
				<Email>godswill.udom@fuoye.edu.ng</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Uduak P.</Name>
				<MidName></MidName>
				<Family>Ise</Family>
				<NameE>Uduak P.</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Ise</FamilyE>
				<Organizations>
				<Organization>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Bingham University, Karu, Nigeria</Organization>
				</Organizations>
				<Countries>
				<Country>Nigeria</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Ayodeji</Name>
				<MidName></MidName>
				<Family>Aturamu</Family>
				<NameE>Ayodeji</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Aturamu</FamilyE>
				<Organizations>
				<Organization>Department of Human Physiology, College of Medicine and Health Sciences, Afe Babalola University, Ado-Ekiti, Nigeria</Organization>
				</Organizations>
				<Countries>
				<Country>Nigeria</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Moses A.</Name>
				<MidName></MidName>
				<Family>Omoirri</Family>
				<NameE>Moses A.</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Omoirri</FamilyE>
				<Organizations>
				<Organization>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Federal University Oye-Ekiti, PMB 373, Oye-Ekiti, Nigeria</Organization>
				</Organizations>
				<Countries>
				<Country>Nigeria</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Mba</Name>
				<MidName></MidName>
				<Family>Ogbonnaya</Family>
				<NameE>Mba</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Ogbonnaya</FamilyE>
				<Organizations>
				<Organization>Department of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, Nnamdi Azikiwe University, Akwa, Nigeria</Organization>
				</Organizations>
				<Countries>
				<Country>Nigeria</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Israel K.</Name>
				<MidName></MidName>
				<Family>Umana</Family>
				<NameE>Israel K.</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Umana</FamilyE>
				<Organizations>
				<Organization>Department of Pharmacology and Toxicology, Faculty of Pharmacy, University of Uyo, Nigeria</Organization>
				</Organizations>
				<Countries>
				<Country>Nigeria</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Jude E.</Name>
				<MidName></MidName>
				<Family>Okokon</Family>
				<NameE>Jude E.</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Okokon</FamilyE>
				<Organizations>
				<Organization>Department of Pharmacology and Toxicology, Faculty of Pharmacy, University of Uyo, Nigeria</Organization>
				</Organizations>
				<Countries>
				<Country>Nigeria</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Drug compounding</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Herbal medicine</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Toxicology</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Gliosis</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Haematology</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>Abebe W. Herbal medication: potential for adverse interactions with analgesic drugs. J Clin Pharmacol Ther 2002; 27(6): 391-401.##Aregheore EM. Nutritive value and inherent anti-nutritive factors in four indigenous edible leafy vegetables in human nutrition in Nigeria: a review. J Food Resource Sci 2012; 1: 1-14.##Ejoh RA, Tanya AN, Djuikwo NA, Mbofung CM. Effect of processing and preservation methods on vitamin C and total carotenoid level of some Vernonia (bitter leaf) species. Afr J Food Agric Nutr Dev 2005; 5: 105-117.##Ekor M. (2014). The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front Pharmacol, 4, 177.##Elston GN. Cortex, cognition and the cell: new insights into the pyramidal neuron and prefrontal function. Cerebral cortex 2003; 13(11): 1124-1138.##Firenzuoli F, Gori L, Galapai C. Adverse reaction to an adrenergic herbal extracts (Citrus aurantium). Phytomedicine 2005; 12(3): 247-248.##Gordon GRJ, Mulligan SJ, Madvicar BA. Astrocyte control of the cerebrovasculature. Glia 2007; 55(12): 1214-1221.##Guizzetti M, Kavanagh TJ, Costa LG. Measurements of astrocyte proliferation. Methods Mol Biol 2011; 758: 349-359.##Hoffbrand AV. Megaloblastic anaemia, In: Hoffband AV, Lewis SM, Tuddenham EGD, editors. Postgraduate haematology. 4th ed. New York: Oxford University Press, 2001.##Maner BS, Moosavi L. Mean corpuscular volume. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021. PMID: 31424859. https://www.ncbi.nlm.nih.gov/books/NBK545275/ [Accessed on July 23 2022].##Marcus R, Coulston AM. Water-soluble vitamins: the vitamin b complex and ascorbic acid, In: Hardman JG, Limbird LE, editors. Goodman and Gilman’s the pharmacological basis of therapeutics. 10th ed. New York: McGraw-Hill Medical Publishing Division, 2001.##National Research Council. Guide for the care and use of laboratory animals. Washington DC: National Academies, 2011.##Osilesi O, Adeiyi A, Ogunyemi EO, Fakunle JB. The glycaemic response to selected fruits and vegetables in Nigerian diabetics. Afr J Med Pharm Sci 1997; 1: 1-6.##Pan SY, Litscher G, Gao SH, Zhou SF, Yu ZL, Chen HQ, et al. Historical perspective of traditional indigenous medical practices: the current renaissance and conservation of herbal resources. Evid Based Complement Alternat Med. 2014; 2014: 525340.##Salami I, Friel KM, Martin JH. Pyramidal tract stimulation restores normal corticospinal tract connections and visuomotor skill after early postnatal motor cortex activity blockade. J Neurosci 2008; 28(29): 7426-7434.##Shiel WC. Herbs toxicities and drug interactions. In: Stöppler MC, editors. [Document on the internet], 2014. https://www.medicinenet.com/script/main/art.asp?articlekey=7506 [Accessed on September 15 2021]##Solaade A. Assorted herbal mixtures: Herbs or poison? [Document on the internet], 2015. https://parroteye.blogspot.com/2 015/01/herbs-or-poison.html [Accessed on September 15 2021]##Udom GJ. Toxicological evaluation and health risk assessment a polyherbal mixture (Dr Iguedo Goko Cleanser®) sold in Uyo and its environs [PhD Thesis]. Uyo, Nigeria: University of Uyo; 2021.##Udom GJ, Okokon JE, Udobang JA, Obot DN, Asuquo IE. Nephrotoxicity assessment of Dr Iguedo Goko Cleanser® in exposed Wistar rats. Asian J Res Med Pharm Sci 2020a; 9(1): 30-40.##Udom GJ, Okokon JE, Udobang JA, Onyeukwu NJ, Obot DN, Asuquo IE. Hepatotoxicity assessment of a polyherbal mixture in exposed Wistar rats. Asian J Res Reports Hepatol 2020b; 2(1): 14-22.##Udom GJ, Udobang JA, Obot DN, Onyeukwu NJ, Asuquo IE, Okokon JE. Toxicological assessment of a polyherbal mixture on organ weights and hormonal profile in exposed Wistar rats. Asian J Res Reports Endocrinol 2020c; 3(2): 29-36.##Udom GJ, Okokon JE, Udobang JA, Obot DN, Onyeukwu NJ. Subchronic toxicological assessment of Dr Iguedo Goko Cleanser® on lipid profile and serum antioxidant enzymes in exposed Wistar rats. Asian J Biol 2020d; 9(4): 16-25.##Wilson CH, Ali ES, Serimgeour N, Martin AM, Hua J, Talllis GA, Rychkov GY, Baritt GJ. Steatotis inhibits liver cell store-operated Ca2+ entry and reduces ER Ca2+ through a protein kinase C-dependent mechanism. Biochem 2015; 466(2): 379-390.##Yemitan OK, Adeyemi OO, Izegbu MC. Toxicological and reversibility assessment of Dalbergia saxatilis root extracts on body and organ weights, hepatic functions and peroxidation in rats. Eur J Med Plants 2015; 11(4): 1-13.##Yemitan OK, Adeyemi OO. Toxicity studies of the aqueous root extract of Lecaniodiscus cupanioides. Nig J Health Biomed Sci 2004; 3: 20-23.##Yu ASL. Haematologic aspects of kidney disease. In: Yu ASL, Chertow GM, Lucyckx V, editors. Brenner and Rector’s The Kidney. 11th ed. Philadelphia: Elsevier, 2019.## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>Cardioprotective effects of Ganoderma lucidum on isoproterenol–induced heart failure</TitleF>
		<TitleE></TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Introduction: Ganoderma lucidum (G. lucidum), a medicinal mushroom, exerts protective effects on cardiovascular diseases but, it&#8217;s effect in isoproterenol-induced heart failure has not been studied. Therefore, the aim of the present study was whether G. lucidum has protective effects in isoproterenol-induced heart failure.
Methods: Thirty male Wistar rats were assigned into five groups (n=6) of control, heart failure (HF) and G. lucidum (50, 100 and 200mg/kg). For induction of HF in rats, isoproterenol (5mg/ kg) was injected subcutaneously for two weeks. In G. lucidum treated groups, G. lucidum was orally gavaged for three weeks and on day 8 isoproterenol was injected for two weeks. Then, Electrocardiogram pattern and cardiodynamic parameters, as well as myeloperoxidase activity, malondialdehyde level, cardiac remodeling and apoptosis were studied.
Results: G. lucidum improved hemodynamic factors such as mean arterial blood pressure as well as electrocardiogram pattern. Pre-treatment with G. lucidum also decreased myeloperoxidase activity, malondialdehyde level and apoptosis in cardiac tissue. Histopathologic results showed a decrease in cardiac necrosis and fibrosis. However, it had no significant effect on cardiac hypertrophy.
Conclusion: Our results show that pre-treatment with G. lucidum demonstrates protective effects against HF, and thereby suggest that G. lucidum can be considered as a possible clinical use for preventive and adjuvant treatment in heart failure.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>271</FPAGE>
			<TPAGE>282</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2022/07/312022/08/222022/07/32021/09/132022/04/72022/06/30
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1401/4/9
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2022/12/32022/11/272022/09/182022/08/272022/09/182022/10/24
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1401/8/2
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>Monireh</Name>
				<MidName></MidName>
				<Family>Seiiedy</Family>
				<NameE>Monireh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Seiiedy</FamilyE>
				<Organizations>
				<Organization>Department of Pharmacology and Toxicology, School of Pharmacy, Urmia University of Medical Sciences, Urmia, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>monirseiiedy72@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Chiman</Name>
				<MidName></MidName>
				<Family>Salehi</Family>
				<NameE>Chiman</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Salehi</FamilyE>
				<Organizations>
				<Organization>Department of Pharmacology and Toxicology, School of Pharmacy, Urmia University of Medical Sciences, Urmia, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>salehichiman@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Morteza</Name>
				<MidName></MidName>
				<Family>Ghasemnejad Berengi</Family>
				<NameE>Morteza</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Ghasemnejad Berengi</FamilyE>
				<Organizations>
				<Organization>Department of Pharmacology and Toxicology, School of Pharmacy, Urmia University of Medical Sciences, Urmia, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>morteza.ghasemnejad@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>mojtaba</Name>
				<MidName></MidName>
				<Family>karimipour</Family>
				<NameE>mojtaba</NameE>
				<MidNameE></MidNameE>
				<FamilyE>karimipour</FamilyE>
				<Organizations>
				<Organization>Department of Anatomy, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>mojtaba_karimipour@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Jafar</Name>
				<MidName></MidName>
				<Family>Rezaie</Family>
				<NameE>Jafar</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Rezaie</FamilyE>
				<Organizations>
				<Organization>Solid Tumor Research Center, Cellular and Molecular Medicine Institute, Urmia University of Medical Sciences, Urmia, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>j.rezaie88@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Shabnam</Name>
				<MidName></MidName>
				<Family>Babataheri</Family>
				<NameE>Shabnam</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Babataheri</FamilyE>
				<Organizations>
				<Organization>1Experimental and Applied Pharmaceutical Research Center, Urmia University of Medical Sciences, Urmia, Iran2Department of Pharmacology and Toxicology, School of Pharmacy, Urmia University of Medical Sciences, Urmia, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>shabnambabataheri90@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Hamid</Name>
				<MidName></MidName>
				<Family>Soraya</Family>
				<NameE>Hamid</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Soraya</FamilyE>
				<Organizations>
				<Organization>Experimental and Applied Pharmaceutical Research Center, Urmia University of Medical Sciences, Urmia, IranDepartment of Pharmacology and Toxicology, School of Pharmacy, Urmia University of Medical Sciences, Urmia, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>hamid_soraya2000@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Ganoderma lucidum</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Heart failure</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Isoproterenol</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Inflammation</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Oxidative stress</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Apoptosis</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>Abbaszadeh S, Javidmehr A, Askari B, Janssen PML, Soraya H. Memantine, an NMDA receptor antagonist, attenuates cardiac remodeling, lipid peroxidation and neutrophil recruitment in heart failure: A cardioprotective agent?. Biomed Pharmacother 2018; 108:1237-1243.##Akihisa T, Nakamura Y, Tagata M, Tokuda H, Yasukawa K, Uchiyama E, et al. Anti-inflammatory and anti-tumor-promoting effects of triterpene acids and sterols from the fungus Ganoderma lucidum. Chem Biodivers 2007; 4:224-231.##Anzai T. Post-infarction inflammation and left ventricular remodeling: a double-edged sword. Circ J 2013; 77:580-587.##Benjamin IJ, Jalil JE, Tan LB, Cho K, Weber KT, Clark WA. Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis. Circ Res 1989; 65:657-670.##Bishop KS, Kao CH, Xu Y, Glucina MP, Paterson RRM, Ferguson LR. From 2000 years of Ganoderma lucidum to recent developments in nutraceuticals. Phytochemistry 2015; 114:56-65.##Chen HS, Tsai YF, Lin S, Lin CC, Khoo KH, Lin CH, et al. Studies on the immuno-modulating and anti-tumor activities of Ganodermalucidum (Reishi) polysaccharides. Bioorg Med Chem 2004; 12:5595-5601.##Chen J, Shi Y, He L, Hao H, Wang B, Zheng Y, et al. Protective roles of polysaccharides from Ganoderma lucidum on bleomycin-induced pulmonary fibrosis in rats. Int J Biol Macromol 2016; 92:278-281.##Costa S, Reina-Couto M, Albino-Teixeira A, Sousa . Statins and oxidative stress in chronic heart failure. Rev Port Cardiol 2016; 35:41-57.##Giordano FJ. Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest 2005; 115:500-508.##Hsu MJ, Lee SS, Lin WW. Polysaccharide purified from Ganoderma lucidum inhibits spontaneous and Fas-mediated apoptosis in human neutrophils through activation of the phosphatidylinositol 3 kinase/Akt signaling pathway. J Leukoc Biol 2002; 72:207-216.##Ikeguchi M, Hirooka Y, Kaibara N. Quantitative analysis of apoptosis-related gene expression in hepatocellular carcinoma. Cancer 2002; 95:1938-1945.##Jannesar K, Abbaszadeh S, Malekinejad H, Soraya H. Cardioprotective effects of memantine in myocardial ischemia: Ex vivo and in vivo studies. Eur J Pharmacol 2020; 882:173277.##Jefferson BK, Topol EJ. Molecular mechanisms of myocardial infarction. Curr Probl Cardiol 2005; 30:333-374.##Johnson FL. Pathophysiology and etiology of heart failure. Cardiol Clin 2014; 32:9-19.##Kabir Y, Kimura S, Tamura T. Dietary effect of Ganoderma lucidum mushroom on blood pressure and lipid levels in spontaneously hypertensive rats (SHR). J Nutr Sci Vitaminol 1988; 34:433-438.##Karagöz A, Kesici S, Vural A, Usta M, Tezcan B, Semerci T, et al. Cardioprotective effects of Viscum album L. ssp. album (Loranthaceae) on isoproterenol-induced heart failure via regulation of the nitric oxide pathway in rats. Anatol J Cardiol 2016; 16:923-930.##Kim NH, Kang PM. Apoptosis in cardiovascular diseases: mechanism and clinical implications. Korean Circ J 2010; 40:299-305.##Konstam MA, Kramer DG, Patel AR, Maron MS, Udelson JE. Left ventricular remodeling in heart failure: current concepts in clinical significance and assessment. JACC Cardiovasc Imaging 2011;4: 98-108.##Lasukova TV, Arbuzov AG, Maslov LN, Burkova VN. Ganoderma lucidum extract in cardiac diastolic dysfunction and irreversible cardiomyocytic damage in ischemia and reperfusion of the isolated heart. Patol Fiziol Eksp Ter 2008; (1):22-25.##Lasukova TV, Maslov LN, Arbuzov AG, Burkova VN, Inisheva LI. Cardioprotective activity of Ganoderma lucidum extract during total ischemia and reperfusion of isolated heart. Bull Exp Biol Med 2015; 158:739-741.##Li F, Zhang Y, Zhong Z. Antihyperglycemic effect of Ganoderma lucidum polysaccharides on streptozotocin-induced diabetic mice. Int J Mol Sci 2011; 12:6135-6145.##Li WJ, Li L, Zhen WY, Wang LF, Pan M, Lv JQ, et al. Ganoderma atrum polysaccharide ameliorates ROS generation and apoptosis in spleen and thymus of immunosuppressed mice. Food Chem Toxicol 2017; 99:199-208.##Lin ZB, Zhang HN. Anti-tumor and immunoregulatory activities of Ganoderma lucidum and its possible mechanisms. Acta Pharmacol Sin 2004; 25: 1387-1395.##Loria V, Dato I, Graziani F, Biasucci LM. Myeloperoxidase: a new biomarker of inflammation in ischemic heart disease and acute coronary syndromes. Mediators inflamm 2008; 2008:135625.##Ma T, Zhu D, Chen D, Zhang Q, Dong H, Wu W, et al. Sulforaphane, a natural isothiocyanate compound, improves cardiac function and remodeling by inhibiting oxidative stress and inflammation in a rabbit model of chronic heart failure. Med Sci Monit 2018; 24:1473-1483.##Meng J, Yang B, Protective Effect of Ganoderma (Lingzhi) on Cardiovascular System. Adv Exp Med Biol 2019; 1182:181-199.##Mullane KM, Kraemer R, Smith B. Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemie myocardium. J Pharmacol Methods 1985; 14:157-67.##Nakamura T, Mizuno S, Matsumoto K, Sawa Y, Matsuda H, Nakamura T. Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF. J Clin Invest 2000; 106:1511-1519.##Qiao J, Dou Z, Wu F, Meng G, Chen H, Zhen H, Effects of Ganoderma lucidum polysaccharides combined with metformin on myocardial structure and hemodynamics in type 2 diabetic rats. Chinese Pharmacol. Bull 2016; 32:1012-1016.##Rameshrad M, Soraya H, Maleki-Dizaji N, Vaez H, Garjani A. A-769662, a direct AMPK activator, attenuates lipopolysaccharide-induced acute heart and lung inflammation in rats. Mol Med Rep 2016; 13:2843-2849.##Sargowo D, Ubaidillah N, Handayani O, Widya A, Vittryaturida V, Siwi K, et al. PS 02-02 Effect Ganoderma lucidum polysaccharide peptides as anti-hypertension, anti-lipid, anti-oxidant, anti-inflammation in high risk patients of atherosclerosis. J. Hypertens 2016; 34: e105.##Sedmera D, Neckar J, Benes J Jr, Pospisilova J, Petrak J, Sedlacek K, et al. Changes in myocardial composition and conduction properties in rat heart failure model induced by chronic volume overload. Front Physiol 2016; 7:367.##Senoner T, Dicht W. Oxidative stress in cardiovascular diseases: still a therapeutic target? Nutrients 2019; 11: E2090.##Sinha N, Dabla PK. Oxidative stress and antioxidants in hypertension–a current review. Curr Hypertens Rev 2015; 11:132-142.##Siwulski M, Sobieralski K, Golak-Siwulska I, Sokół S, Sękara A. Ganoderma lucidum (Curt.: Fr.) Karst.–health-promoting properties. Herba Polonica 2015; 61:105-118.##Soraya H, Khorrami A, Garjani A, Maleki-Dizaji N, Garjani A. Acute treatment with metformin improves cardiac function following isoproterenol induced myocardial infarction in rats. Pharmacol Rep 2012; 64:1476-1484.##Sun XZ, Liao Y, Li W, Guo LM. Neuroprotective effects of Ganoderma lucidum polysaccharides against oxidative stress-induced neuronal apoptosis. Neural Regen Res 2017; 12:953-958.##Susilo RJK, Winarni D, Husen SA, Hayaza S, Punnapayak H, Wahyuningsih SPA, et al. Hepatoprotective effect of crude polysaccharides extracted from Ganoderma lucidum against carbon tetrachloride-induced liver injury in mice. Vet World 2019; 12:1987-1991.##Tsutsui H, Kinugawa S, Matsushima S. Oxidative stress and heart failure. Am J Physiol Heart Circ Physiol 2011; 301:H2181-190.##Veena RK, Ajith TA, Janardhanan KK. Lingzhi or Reishi medicinal mushroom, Ganoderma lucidum (Agaricomycetes), prevents doxorubicin-induced cardiotoxicity in rats. Int J Med Mushrooms 2018; 20:761-774.##Wachtel-Galor S, Tomlinson B, Benzie IF. Ganoderma lucidum (‘Lingzhi’), a Chinese medicinal mushroom: biomarker responses in a controlled human supplementation study. Br J Nutr 2004; 91:263-269.##Waty IS, Wihastuti TA, WidodoMA SargowoD. Effect of polysaccharide peptide (Ganodermalucidum) against inflammatory processes focused on IL-6 and hsCRPin atherosclerosis. J. Hypertens 2015; 33: e38.##Wong KL, Chao HH, Chan P, Chang LP, Liu CF. Antioxidant activity of Ganoderma lucidum in acute ethanol-induced heart toxicity. Phytother Res 2004; 18:1024-1026.##Xie YZ, Yang F, Tan W, Li X, Jiao C, Huang R, et al. The anti-cancer components of Ganoderma lucidum possesses cardiovascular protective effect by regulating circular RNA expression. Oncoscience 2016; 3:203-207.##Xue H, Qiao J, Meng G, Wu F, Luo J, Chen H, et al. Effect of Ganoderma lucidum polysaccharides on hemodynamic and antioxidation in T2DM rats. Zhongguo Zhong Yao Za Zhi 2010; 35:339-343.##Xu F, Li X, Xiao X, Liu LF, Zhang L, Lin PP, et al. Effects of Ganoderma lucidum polysaccharides against doxorubicin-induced cardiotoxicity. Biomed Pharmacother 2017; 95:504-512.##Young IS, Trimble ER. Measurement of malondialdehyde in plasma by high performance liquid chromatography with fluorimetric detection. Ann Clin Biochem 1991; 28:504-508.##Zeng P, Guo Z, Zeng X, Hao C, Zhang Y, Zhang M, et al. Chemical, biochemical, preclinical and clinical studies of Ganoderma lucidum polysaccharide as an approved drug for treating myopathy and other diseases in China. J Cell Mol Med 2018; 22:3278-3297.##Zhang W, Zhang Q, Deng W, Li Y, Xing G, Shi X, et al. Neuroprotective effect of pretreatment with Ganoderma lucidum in cerebral ischemia/reperfusion injury in rat hippocampus. Neural Regen Res 2014; 9:1446-1452.##Zhao W, Jiang X, Deng W, Lai Y, Wu M, Zhang Z. Antioxidant activities of Ganoderma lucidum polysaccharides and their role on DNA damage in mice induced by cobalt-60 gamma-irradiation. Food Chem Toxicol 2012; 50:303-309.## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>The effect of broad-spectrum antibiotic ceftriaxone on net colonic water and ion transport in vivo</TitleF>
		<TitleE></TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Introduction: The molecular mechanism of idiopathic antibiotic-associated diarrhea is not clear. Сeftriaxone, a third-generation cephalosporin, is a broad-spectrum antibiotic and diarrhea is the main side-effect of ceftriaxone treatment. The present study tested the hypothesis that ceftriaxone-induced diarrhea is associated with a shift in microbiota composition followed by the alteration in colonic water/ion transport, the expression pattern of transporters and epithelial barrier function.
Methods: Male Wistar rats were treated daily with ceftriaxone (50 mg/kg, i.m.) for 5 or 14 days. Epithelial net water and ion transport (Na+ , K+ , Cl- ) were evaluated on the 6th or 15th day respectively by isolated colonic loop perfusion technique in vivo. Gene expression by RT-PCR, glycoproteins levels by PAS-staining, and microbiota by culture method on the elective medium were evaluated.
Results: Decreases in Na+ and water absorption, surface mucus layer, and Scnn1b and Aqp8 gene expression were associated with more severe diarrhea after 5 days-antibiotic treatment. After 14-days of antibiotic treatment, fewer animals with diarrhea were observed. At the same time, there was a decrease of Cl- and an increase in Na+ absorption, along with increased mucus secretion and upregulation of Cftr, Scnn1b, Slc9a3, Muc2, Ocln, and Tjp1 gene expression. These changes were accompanied by an increase in the number of culturable conditionally pathogenic microbiota after 5 days of treatment which almost returned to the control value after 14 days of treatment.
Conclusion: We concluded that the observed transitory antibiotic-associated diarrhea was a well-orchestrated physiological defense response at the molecular level driven by the shift in normal microbiota composition.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>283</FPAGE>
			<TPAGE>295</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2022/07/312022/08/222022/07/32021/09/132022/04/72022/06/302021/08/24
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1400/6/2
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2022/12/32022/11/272022/09/182022/08/272022/09/182022/10/242022/12/3
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1401/9/12
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>Taisa</Name>
				<MidName></MidName>
				<Family>Dovbynchuk</Family>
				<NameE>Taisa</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Dovbynchuk</FamilyE>
				<Organizations>
				<Organization>Taras Shevchenko National University of Kyiv, Kyiv, Ukraine</Organization>
				</Organizations>
				<Countries>
				<Country>Ukraine</Country>
				</Countries>
				<EMAILS>
				<Email>mtaisa80@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Tetiana</Name>
				<MidName></MidName>
				<Family>Chervinska</Family>
				<NameE>Tetiana</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Chervinska</FamilyE>
				<Organizations>
				<Organization>Taras Shevchenko National University of Kyiv, Kyiv, Ukraine</Organization>
				</Organizations>
				<Countries>
				<Country>Ukraine</Country>
				</Countries>
				<EMAILS>
				<Email>chervinska.tetiana@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Liudmyla</Name>
				<MidName></MidName>
				<Family>Zakordonets</Family>
				<NameE>Liudmyla</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Zakordonets</FamilyE>
				<Organizations>
				<Organization>International European University, Kyiv, Ukraine</Organization>
				</Organizations>
				<Countries>
				<Country>Ukraine</Country>
				</Countries>
				<EMAILS>
				<Email>lzakordonets2@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Alevtina</Name>
				<MidName></MidName>
				<Family>Huet</Family>
				<NameE>Alevtina</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Huet</FamilyE>
				<Organizations>
				<Organization>Taras Shevchenko National University of Kyiv, Kyiv, Ukraine</Organization>
				</Organizations>
				<Countries>
				<Country>Ukraine</Country>
				</Countries>
				<EMAILS>
				<Email>alevtina.dranitsina@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Tetiana</Name>
				<MidName></MidName>
				<Family>Serhiichuk</Family>
				<NameE>Tetiana</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Serhiichuk</FamilyE>
				<Organizations>
				<Organization>Taras Shevchenko National University of Kyiv, Kyiv, Ukraine</Organization>
				</Organizations>
				<Countries>
				<Country>Ukraine</Country>
				</Countries>
				<EMAILS>
				<Email>stm1972@bigmir.net</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Liudmyla</Name>
				<MidName></MidName>
				<Family>Ostapchenko</Family>
				<NameE>Liudmyla</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Ostapchenko</FamilyE>
				<Organizations>
				<Organization>Taras Shevchenko National University of Kyiv, Kyiv, Ukraine</Organization>
				</Organizations>
				<Countries>
				<Country>Ukraine</Country>
				</Countries>
				<EMAILS>
				<Email>l_ostap@univ.kiev.ua</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Ganna</Name>
				<MidName></MidName>
				<Family>Tolstanova</Family>
				<NameE>Ganna</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Tolstanova</FamilyE>
				<Organizations>
				<Organization>Taras Shevchenko National University of Kyiv, Kyiv, Ukraine</Organization>
				</Organizations>
				<Countries>
				<Country>Ukraine</Country>
				</Countries>
				<EMAILS>
				<Email>ganna.tolstanova@knu.ua</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Antibiotic-associated diarrhea</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Ceftriaxone</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Colon</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Ion transport</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Epithelial barrier</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>Akiba Y, Guth PH, Engel E, Nastaskin I, Kaunitz JD. Dynamic regulation of mucus gel thickness in rat duodenum. Am J Physiol Gastrointest Liver Physiol 2000; 279(2): G437–47.##Benjamin HM, Horace RTW. Clostridium difficile infection and antibiotic-associated diarrhea. Clin Med (Lond) 2018; 18(3): 237–41.##Camilleri M, Carlson P, Chedid V, Vijayvargiya P, Burton D, Busciglio I. Aquaporin Expression in Colonic Mucosal Biopsies From Irritable Bowel Syndrome With Diarrhea. Clin Transl Gastroenterol 2019; 10(4), e00019.##Chelakkot C, Ghim J. Ryu SH. Mechanisms regulating intestinal barrier integrity and its pathological implications. Exp Mol Med 2018; 50, 103.##Chomczynski P, Sacchi N. The single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction: twenty-something years on. Nature Protocols 2006; 1(2), 581–5.##Dovbynchuk T, Zakordonets L, Baban V, Chervinska T, Tolstanova G. The effect of multi-spicies probiotic on antibiotic-induced changes in colonic ion and water transport. Res J Pharma, Biol Chem Sci 2015a; 6(6): 896-901.##Dovbynchuk T, Zakordonets L, Putnikov A, Vareniuk I, Tiapko О, Roslova N, et al. Net water transport via rat colon epitelium under the experimental dysbiosis. Fiziol Zh 2015b; 61(6):76-85.##Durham SH, Wingler MJ, Eiland LS. Appropriate Use of Ceftriaxone in the Emergency Department of a Veteran’s Health Care System. J Pharm Technol 2017; 33(6):215-8.##Gareau MG, Barrett KE. Fluid and electrolyte secretion in the inflamed gut: novel targets for treatment of inflammation-induced diarrhea. Curr Opin Pharmacol 2013; 13(6): 895–9.##Ghosh S, Dai C, Brown K, Rajendiran E, Makarenko S, Baker J, Gibson DL. Colonic microbiota alters host susceptibility to infectious colitis by modulating inflammation, redox status, and ion transporter gene expression Am J of Physiol. Gastrointest and Liver Physiol 2011; 301(1): G39-49.##Giannella RA, Serumag J, Walls D, Drake KW. Effect of clindamycin on intestinal water and glucose transport in the rat. Gastroenterology 1981; 80(5 pt 1): 907-13.##Goldhill JM, Rose K, Percy WH. Effects of antibiotics on epithelial ion transport in the rabbit distal colon in-vitro. J Pharm Pharmacol 1996; 48(6):651-6.##Gustafsson JK, Navabi N, Rodriguez-Piñeiro AM, Alomran AHA, Premaratne P, Fernandez HR, et al. Dynamic changes in mucus thickness and ion secretion during Citrobacter rodentium infection and clearance. PloS one 2013; 8(12): e84430.##Holota Y, Dovbynchuk T, Kaji I, Vareniuk I, Dzyubenko N, Chervinska T, et al. The long-term consequences of antibiotic therapy: Role of colonic short-chain fatty acids (SCFA) system and https://intestinal barrier integrity. PLoS One 2019; 14(8): e0220642.##Hoque KM, Chakraborty S, Sheikh IA. Woodward OM. New advances in the pathophysiology of intestinal ion transport and barrier function in diarrhea and the impact on therapy. Expert Rev Anti Infect Ther 2012; 10(6): 687-99.##Hove H, Tvede M, Mortensen PB. Antibiotic-associated diarrhoea, Clostridium difficile, and short-chain fatty acids. Scand J Gastroenterol 1996; 31(7): 688-93.##Kiela PR, Ghishan FK. Ion transport in the intestine. Curr Opin Gastroenterol 2009; 25(2): 87-91.##Konturek PC, Brzozowski T, Pierzchalski P, Kwiecien S, Pajdo R, Hahn EG, et al. Activation of genes for spasmolytic peptide, transforming growth factor alpha and for cyclooxygenase (COX)-1 and COX-2 during gastric adaptation to aspirin damage in rats. Aliment Pharmacol Ther 1998; 12(8): 767-77.##Kunzelmann K, Mall M. Electrolyte transport in the mammalian colon: mechanisms and implications for disease. Physiol Rev 2002; 82(1): 245-89.##Liu Q, Yu Z, Tian F. et al. Surface components and metabolites of probiotics for regulation of intestinal epithelial barrier. Microb Cell Fact 2020; 19, 23.##Liu Q, Yu Z, Tian F, Zhao J, Zhang H, Zhai Q, et al. Surface components and metabolites of probiotics for regulation of intestinal epithelial barrier. Microb Cell Fact 2020; 19, 23.##Lomasney KW, Hyland NP. The application of Ussing chambers for determining the impact of microbes and probiotics on intestinal ion transport. Can J Physiol Pharmacol 2013; 91(9): 663-70.##Marchelletta RR, Gareau MG, McCole DF, Okamoto S, Roel E, Klinkenberg R, et al. Altered expression and localization of ion transporters contribute to diarrhea in mice with Salmonella-induced enteritis. Gastroenterology 2013; 145(6): 1358–68.e1–4.##National Research Council. Guide for the Care and Use of Laboratory Animals: Eighth Edition. Washington, DC: The National Academies Press. 2011.##Nelson Rl, Kelsey P, Leeman H, Meardon N, Patel H, et al. Antibiotic treatment for Clostridium difficile -associated diarrhea in adults ( Review ). Cochrane Database Syst Rev 2011; (9):CD004610.##Neuman G, Boodhan S, Wurman I, Koren G, Bitnun A, et al. Ceftriaxone-induced immune hemolytic anemia. Ann Pharmacother 2014; 48(12): 1594-1604.##Piliponsky AM, Romani L. The contribution of mast cells to bacterial and fungal infection immunity. Immunol Rev 2018; 282(1):188-97.##Roberts M, Hladky SB, Pickles RJ, Cuthbert AW. Stimulation of sodium transport by duramycin in cultured human colonic epithelia. J Pharmacol Exp Ther 1991; 259(3): 1050–8.##Sakai H, Sagara A, Matsumoto K, Jo A, Hirosak A, Takase K, Narita M. Neutrophil recruitment is critical for 5-fluorouracil-induced diarrhea and the decrease in aquaporins in the colon. Pharmacol Res 2014; 87: 71–9.##Sambrook J, Russell DW. Separation of RNA according to size: electrophoresis of glyoxylated RNA through agarose gels. CSH Protoc 2006; 1: 23-8.##Schedl HP. Use of polyethylene glycol and phenol red as unabsorbed indicators for intestinal absorption studies in man. Gut 1966; 7(2): 159-63.##Shubha P, Arivarasu NA, Tarunmeet G, Alip B, Seema S, Ravinder KG, et al. All-trans-retinoic Acid Increases SLC26A3 DRA (Down-regulated in Adenoma) Expression in Intestinal Epithelial Cells via HNF-1β J Biol Chem 2015; 290, 15066-77.##Sladen GE, Harries JT. Studies on the effects of unconjugated dihydroxy bile salts on rat small intestinal function in vivo. Biochim Biophys Acta. 1972; 288(2): 443-56.##Spehlmann ME, Dann SM, Hruz P, Hanson E, McCole DF, Eckmann L. CXCR2-dependent mucosal neutrophil influx protects against colitis-associated diarrhea caused by an attaching/effacing lesion-forming bacterial pathogen. J Immun 2009; 183(5): 3332-43.##Thomson SR, Ommurugan B, Patil N. Ceftriaxone induced hypersensitivity reactions following intradermal skin test: Case Series. J Clin Diagn Res 2017; 11(10) 3,672.##Tomas J, Reygner J, Mayeur C, Ducroc R, Bouet S,  Bridonneau C,  et al. Early colonizing Escherichia coli elicits remodeling of rat colonic epithelium shifting toward a new homeostatic state. ISME J2015; 9(1): 46-58.## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>Neuroprotective effects of Tacca chantrieri Andre against lipopolysaccharide-induced cognitive impairment and neuroinflammation</TitleF>
		<TitleE></TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Introduction: Tacca chantrieri Andre is frequently used by traditional healers to alleviate pain and fever, primirily by reducing inflammation. Its rhizome extract possesses remarkable peripheral anti-inflammatory and antioxidant bioactivities. However, there is limited information available regarding its potential anti-neuroinflammation effects. This study aimes to assess the neuroprotective effects of T. chantrieri rhizome ethanol extract (TCE) against lipopolysaccharides (LPS)-induced neuroinflammation.
Methods: Rats were orally administered with TCE at doses of 50, 100, and 200 mg/kg continually for 9 days. On the 7th day of treatment, each rat received a single intraperitoneal injection of LPS (0.83 mg/kg). Cognitive performance was assessed using the Y-maze test and novel object recognition (NOR) test. Thereafter, the proinflammatory cytokine level in the hippocampus was measured by ELISA.
Results: Systemic LPS administration induced sickness behavior, cognitive impairment, and neuroinflammation. TCE at doses of 100 and 200 mg/kg reversed the LPS-induced behavioral deficits, showing improvements in spontaneous alternation in the Y-maze test and discrimination index in the NOR test. Additionally, pretreatment with TCE at doses of 100 and 200 mg/kg significantly attenuated the LPS-induced increase in protein expression of TNF-&#945;.
Conclusion: TCE exhibited neuroprotective effects against LPS-induced cognitive deficits and suppressed the production of pro-inflammatory mediators in a dose-dependent manner. These findings indicate that TCE may hold therapeutic potential in preventing neuroinflammation associated cognitive impairment. However, further studies are necessary to validate the possible mechanisms of its neuroprotective effects.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>296</FPAGE>
			<TPAGE>306</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2022/07/312022/08/222022/07/32021/09/132022/04/72022/06/302021/08/242022/06/1
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1401/3/11
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2022/12/32022/11/272022/09/182022/08/272022/09/182022/10/242022/12/32022/12/31
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1401/10/10
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>Utcharaporn</Name>
				<MidName></MidName>
				<Family>Kamsrijai</Family>
				<NameE>Utcharaporn</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Kamsrijai</FamilyE>
				<Organizations>
				<Organization>School of Medicine, Mae Fah Luang University, Muang, Chiang Rai 57100, Thailand</Organization>
				</Organizations>
				<Countries>
				<Country>Thailand</Country>
				</Countries>
				<EMAILS>
				<Email>utcharaporn.kam@mfu.ac.th</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Benjamard</Name>
				<MidName></MidName>
				<Family>Thaweethee-Sukjai</Family>
				<NameE>Benjamard</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Thaweethee-Sukjai</FamilyE>
				<Organizations>
				<Organization>School of Medicine, Mae Fah Luang University, Muang, Chiang Rai 57100, Thailand</Organization>
				</Organizations>
				<Countries>
				<Country>Thailand</Country>
				</Countries>
				<EMAILS>
				<Email>Benjamard.suk@mfu.ac.th</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Narudol</Name>
				<MidName></MidName>
				<Family>Teerapattarakan</Family>
				<NameE>Narudol</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Teerapattarakan</FamilyE>
				<Organizations>
				<Organization>School of Medicine, Mae Fah Luang University, Muang, Chiang Rai 57100, Thailand</Organization>
				</Organizations>
				<Countries>
				<Country>Thailand</Country>
				</Countries>
				<EMAILS>
				<Email>Narudol.tee@mfu.ac.th</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Keerati</Name>
				<MidName></MidName>
				<Family>Wanchai</Family>
				<NameE>Keerati</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Wanchai</FamilyE>
				<Organizations>
				<Organization>School of Medicine, Mae Fah Luang University, Muang, Chiang Rai 57100, Thailand</Organization>
				</Organizations>
				<Countries>
				<Country>Thailand</Country>
				</Countries>
				<EMAILS>
				<Email>Keerati.wan@mfu.ac.th</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Poonyawee</Name>
				<MidName></MidName>
				<Family>Jirarattanawan</Family>
				<NameE>Poonyawee</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Jirarattanawan</FamilyE>
				<Organizations>
				<Organization>School of Medicine, Mae Fah Luang University, Muang, Chiang Rai 57100, Thailand</Organization>
				</Organizations>
				<Countries>
				<Country>Thailand</Country>
				</Countries>
				<EMAILS>
				<Email>Poonyawee.jir@mfu.ac.th</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Tacca chantrieri Andre</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Neuroinflammation</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Lipopolysaccharides</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Cognitive deficits</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>Baj T, Seth R. Role of Curcumin in Regulation of TNF-α Mediated Brain Inflammatory Responses. Recent Pat Inflamm Allergy Drug Discov. 2018; 12(1):69-77.##Banks WA, Gray AM, Erickson MA, Salameh TS, Damodarasamy M, Sheibani N, Meabon JS, Wing EE, Morofuji Y, Cook DG, Reed MJ. Lipopolysaccharide-induced blood-brain barrier disruption: roles of cyclooxygenase, oxidative stress, neuroinflammation, and elements of the neurovascular unit. J Neuroinflam. 2015; 25: 12: 223.##Belarbi K, Jopson T, Tweedie D, Arellano C, Luo W, Greig NH, Rosi S. TNF-α protein synthesis inhibitor restores neuronal function and reverses cognitive deficits induced by chronic neuroinflammation. J Neuroinflam 2012; 25: 9-23.##Benito-León J, Contador I, Vega S, Villarejo-Galende A, Bermejo-Pareja F. Non-steroidal anti-inflammatory drugs use in older adults decreases risk of Alzheimer’s disease mortality. PLoS One 2019; 17: 14(9): e0222505.##Calsolaro V, Edison P. Neuroinflammation in Alzheimer’s disease: Current evidence and future directions. Alzheimers Dement 2016; 12(6): 719-32.##Chen WW, Zhang X, Huang WJ. Role of neuroinflammation in neurodegenerative diseases (Review). Mol Med Rep 2016; 13(4):3391-6.##Clarke JR, Cammarota M, Gruart A, Izquierdo I, Delgado-García JM. Plastic modifications induced by object recognition memory processing. Proc Natl Acad Sci USA. 2010 Feb 9; 107(6):2652-7.##Czerniawski J, Miyashita T, Lewandowski G, Guzowski JF. Systemic lipopolysaccharide administration impairs retrieval of context-object discrimination, but not spatial, memory: Evidence for selective disruption of specific hippocampus-dependent memory functions during acute neuroinflammation. Brain Behav Immun 2015; 44: 159-66.##Emery DC, Shoemark DK, Batstone TE, Waterfall CM, Coghill JA, Cerajewska TL, Davies M, West NX, Allen SJ. 16S rRNA Next Generation Sequencing Analysis Shows Bacteria in Alzheimer’s Post-Mortem Brain. Front Aging Neurosci 2017; 20; 9: 195.##Frankola KA, Greig NH, Luo W, Tweedie D. Targeting TNF-α to elucidate and ameliorate neuroinflammation in neurodegenerative diseases. CNS Neurol Disord Drug Targets 2011; 10(3): 391-403.##Huang HT, Kuo YM, Tzeng SF. Intermittent peripheral exposure to lipopolysaccharide induces exploratory behavior in mice and regulates brain glial activity in obese mice. J Neuroinflam 2020; 17(1): 163.##Jin Y, Peng J, Wang X, Zhang D, Wang T. Ameliorative Effect of Ginsenoside Rg1 on Lipopolysaccharide-Induced Cognitive Impairment: Role of Cholinergic System. Neurochem Res 2017; 42(5): 1299-1307.##Kim HS, Kim S, Shin SJ, Park YH, Nam Y, Kim CW, Lee KW, Kim SM, Jung ID, Yang HD, Park YM, Moon M. Gram-negative bacteria and their lipopolysaccharides in Alzheimer’s disease: pathologic roles and therapeutic implications. Transl Neurodegener 2021; 10(1): 49.##Kraeuter AK, Guest PC, Sarnyai Z. The Y-Maze for Assessment of Spatial Working and Reference Memory in Mice. Methods Mol Biol 2019; 1916: 105-111.##Lee JW, Nam H, Kim LE, Jeon Y, Min H, Ha S, Lee Y, Kim SY, Lee SJ, Kim EK, Yu SW. TLR4 (toll-like receptor 4) activation suppresses autophagy through inhibition of FOXO3 and impairs phagocytic capacity of microglia. Autophagy 2019; 15(5): 753-770.##Li W, Ali T, He K, Liu Z, Shah FA, Ren Q, Liu Y, Jiang A, Li S. Ibrutinib alleviates LPS-induced neuroinflammation and synaptic defects in a mouse model of depression. Brain Behav Immun 2021; 92: 10-24.##Liu JQ, Zhao M, Zhang Z, Cui LY, Zhou X, Zhang W, Chu SF, Zhang DY, Chen NH. Rg1 improves LPS-induced Parkinsonian symptoms in mice via inhibition of NF-κB signaling and modulation of M1/M2 polarization. Acta Pharmacol Sin 2020; 41(4): 523-534.##Liu Y, Zhang Y, Zheng X, Fang T, Yang X, Luo X, Guo A, Newell KA, Huang XF, Yu Y. Galantamine improves cognition, hippocampal inflammation, and synaptic plasticity impairments induced by lipopolysaccharide in mice. J Neuroinflam 2018; 18; 15(1): 112.##Lopez-Rodriguez AB, Hennessy E, Murray CL, Nazmi A, Delaney HJ, Healy D, Fagan SG, Rooney M, Stewart E, Lewis A, de Barra N, Scarry P, Riggs-Miller L, Boche D, Cunningham MO, Cunningham C. Acute systemic inflammation exacerbates neuroinflammation in Alzheimer’s disease: IL-1β drives amplified responses in primed astrocytes and neuronal network dysfunction. Alzheimers Dement 2021; 17(10): 1735-1755.##Madhi I, Kim JH, Shin JE, Kim Y. Ginsenoside Re exhibits neuroprotective effects by inhibiting neuroinflammation via CAMK/MAPK/NF‑κB signaling in microglia. Mol Med Rep 2021; 24(4): 698.##Miao HH, Zhang Y, Ding GN, Hong FX, Dong P, Tian M. Ginsenoside Rb1 attenuates isoflurane/surgery-induced cognitive dysfunction via inhibiting neuroinflammation and oxidative stress. Biomed Environ Sci 2017, 30(5): 363-372.##Marefati N, Beheshti F, Memarpour S, Bayat R, Naser Shafei M, Sadeghnia HR, Ghazavi H, Hosseini M. The effects of acetyl-11-keto-β-boswellic acid on brain cytokines and memory impairment induced by lipopolysaccharide in rats. Cytokine 2020; 131: 155107.##Passamonti L, Tsvetanov KA, Jones PS, Bevan-Jones WR, Arnold R, Borchert RJ, Mak E, Su L, O’Brien JT, Rowe JB. Neuroinflammation and Functional Connectivity in Alzheimer’s Disease: Interactive Influences on Cognitive Performance. J Neurosci 2019; 4; 39(36):7218-7226.##Rajendran L, Paolicelli RC. Microglia-Mediated Synapse Loss in Alzheimer’s Disease. J Neurosci. 2018;38(12):2911-2919.##Reitz C, Brayne C, Mayeux R. Epidemiology of Alzheimer disease. Nat Rev Neurol 2011; 7(3):137-52.##Rujjanawate C, Chairat N. Use of bat flower’s rhizome powder to relieve muscle inflammation.” J Community Develop Life Qual 2018; 1(1): 91-96.##Sparkman NL, Martin LA, Calvert WS, Boehm GW. Effects of intraperitoneal lipopolysaccharide on morris maze performance in year-old and 2-month-old female C57BL/6J mice. Behav Brain Res 2005; 159(1): 145-51.##Sudheimer KD, O’Hara R, Spiegel D, Powers B, Kraemer HC, Neri E, Weiner M, Hardan A, Hallmayer J, Dhabhar FS. Cortisol, cytokines, and hippocampal volume interactions in the elderly. Front Aging Neurosci 2014; 3; 6:153.##Tiamjan R, Panthong A, Taesotikul T, Rujjanawate C, Taylor WC, Kanjanapothi D. Hypotensive activity of Tacca chantrieri. and its hypotensive principles. Pharma Biol 2007; 45(6): 481-485.##Vargas-Caraveo A, Sayd A, Robledo-Montaña J, Caso JR, Madrigal JLM, García-Bueno B, Leza JC. Toll-like receptor 4 agonist and antagonist lipopolysaccharides modify innate immune response in rat brain circumventricular organs. J Neuroinflam 2020; 17(1): 6.##Wahl D, Coogan SC, Solon-Biet SM, de Cabo R, Haran JB, Raubenheimer D, Cogger VC, Mattson MP, Simpson SJ, Le Couteur DG. Cognitive and behavioral evaluation of nutritional interventions in rodent models of brain aging and dementia. Clin Interv Aging 2017; 8; 12: 1419-1428.##Wang WY, Tan MS, Yu JT, Tan L. Role of pro-inflammatory cytokines released from microglia in Alzheimer’s disease. Ann Transl Med. 2015; 3(10): 136.##Wu CF, Bi XL, Yang JY, Zhan JY, Dong YX, Wang JH, Wang JM, Zhang R, Li X. Differential effects of ginsenosides on NO and TNF-alpha production by LPS-activated N9 microglia. Int Immunopharmacol. 2007; 7(3): 313-320.##Yang Y, Gong Q, Wang W, Mao YL, Wang XR, Yao S, Zhang HY, Tang C, Ye Y. Neuroprotective and anti-inflammatory ditetrahydrofuran-containing diarylheptanoids from Tacca chantrieri. J Nat Prod. 2020; 83(12): 3681-3688.##Yang Y, Zhong W, Zhang Y, Cheng Y, Lai H, Yu H, Feng N, Han Y, Huang R, Zhai Q. Sustained Inflammation Induced by LPS Leads to Tolerable Anorexia and Fat Loss via Tlr4 in Mice.” J Inflamm Res. 2022; 15: 5635-5648.##Yen PH, Chi VT, Kiem PV, Tai BH, Quang TH, Nhiem NX, Anh Hle T, Ban NK, Thanh BV, Minh CV, Park S, Kim SH. Spirostanol saponins from Tacca vietnamensis and their anti-inflammatory activity. Bioorg Med Chem Lett 2016; 1; 26(15): 3780-4.##Yin S, Shao J, Wang X, Yin X, Li W, Gao Y, Velez de-la-Paz OI, Shi H, Li S. Methylene blue exerts rapid neuroprotective effects on lipopolysaccharide-induced behavioral deficits in mice. Behav Brain Res 2019; 1; 356: 288-294.##Yokosuka A, Mimaki Y, Sashida Y. Spirostanol saponins from the rhizomes of Tacca chantrieri and their cytotoxic activity. Phytochemistry 2002a; 61(1): 73-8.##Yokosuka A, Mimaki Y, Sashida Y. Steroidal and pregnane glycosides from the rhizomes of Tacca chantrieri. J Nat Prod 2002b; 65(9):1293-8.##Zakaria R, Wan Yaacob WM, Othman Z, Long I, Ahmad AH, Al-Rahbi B. Lipopolysaccharide-induced memory impairment in rats: a model of Alzheimer’s disease. Physiol Res 2017; 22; 66(4):553-565.##Zhan X, Stamova B, Jin LW, DeCarli C, Phinney B, Sharp FR. Gram-negative bacterial molecules associate with Alzheimer disease pathology. Neurology 2016; 29: 87(22): 2324-2332.##Zhao J, Bi W, Xiao S, Lan X, Cheng X, Zhang J, Lu D, Wei W, Wang Y, Li H, Fu Y, Zhu L. Neuroinflammation induced by lipopolysaccharide causes cognitive impairment in mice. Sci Rep 2019; 9:5790.##Zhou M, Xu R, Kaelber DC, Gurney ME. Tumor Necrosis Factor (TNF) blocking agents are associated with lower risk for Alzheimer’s disease in patients with rheumatoid arthritis and psoriasis. PLoS One 2020; 23:15(3): e0229819.## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>Synthesis and evaluation of Escitalopram-loaded niosomes on colon cancer cell lines</TitleF>
		<TitleE></TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Introduction: It has been approved that selective serotonin reuptake inhibitors (SSRIs) may exhibit anti-proliferative or cytotoxic effects on several types of cancers. The aim of the present study was to evaluate the cytotoxic effects of a newly formulated niosome of Escitalopram oxalate on a colorectal cancer cell line.
Methods: The niosomes were prepared using a thin layer hydration method, resulting in particles with a size range between 150 &#8211; 450 nm and spherical morphology. Moreover, its permeability release showed 25% in 4 hours. The cytotoxicity evaluation was performed using a quantitative colorimetric MTT assay.
Results: The cell viability of colon cancer cells after treatment with niosomes and pure escitalopram reduced to 28.3 &#177; 0.83 % and 24.07 &#177; 0.56%, respectively. However, the cytotoxicity assay of escitalopram-loaded niosomes suggested that the anti-proliferative effect of the niosomal formulation of escitalopram was dose and incubation time-dependent.
Conclusion: These results confirm the potential of the anti-proliferative activity of escitalopram-loaded niosomes. Further application to an in vivo model is needed to study various pharmacokinetic and pharmacodynamics parameters to establish its complete therapeutic potential.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>307</FPAGE>
			<TPAGE>318</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2022/07/312022/08/222022/07/32021/09/132022/04/72022/06/302021/08/242022/06/12022/05/2
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1401/2/12
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2022/12/32022/11/272022/09/182022/08/272022/09/182022/10/242022/12/32022/12/312022/12/17
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1401/9/26
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>Faten</Name>
				<MidName></MidName>
				<Family>Eshrati Yeganeh</Family>
				<NameE>Faten</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Eshrati Yeganeh</FamilyE>
				<Organizations>
				<Organization>Islamic Azad University, Tehran, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>ffyeganeh@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Maryam</Name>
				<MidName></MidName>
				<Family>Tabarzad</Family>
				<NameE>Maryam</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Tabarzad</FamilyE>
				<Organizations>
				<Organization>Shahid beheshti university of Medical Sciences, Tehran, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>tabarzad.m@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Hajar</Name>
				<MidName></MidName>
				<Family>Khazraei</Family>
				<NameE>Hajar</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Khazraei</FamilyE>
				<Organizations>
				<Organization>Shiraz University of Medical Sciences: Shiraz, Fars, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>hajarkhazraei@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Mahsa</Name>
				<MidName></MidName>
				<Family>Bourbour</Family>
				<NameE>Mahsa</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Bourbour</FamilyE>
				<Organizations>
				<Organization>Alzahra University, Tehran, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>colorectal@sums.ac.ir</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Escitalopram</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Cell viability</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Niosome</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>MTT assay</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>Akbari V, Abedi D, Pardakhty A, Sadeghi-Aliabadi H. Release studies on ciprofloxacin loaded non-ionic surfactant vesicles. Avicenna J Med Biotechnol 2015; 7: 69.##Alvi IA, Madan J, Kaushik D, Sardana S, Pandey RS, Ali A. Comparative study of transfersomes, liposomes, and niosomes for topical delivery of 5-fluorouracil to skin cancer cells: preparation, characterization, in-vitro release, and cytotoxicity analysis. Anticancer Drugs 2011; 22: 774-782.##Balakrishnan P, Shanmugam S, Lee W S, Lee WM, Kim JO, Oh DH, et al. Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery. Int J Pharm 2009; 377: 1-8.##Balasubramaniam A, Anil Kumar V, Sadasivan Pillai K. Formulation and in vivo evaluation of niosome-encapsulated daunorubicin hydrochloride. Drug Dev Ind Pharm 2002; 28: 1181-1193.##Bayindir ZS, Yuksel N. Characterization of niosomes prepared with various nonionic surfactants for paclitaxel oral delivery. J Pharm Sci 2010; 99: 2049-2060.##Bernsdorff C, Wolf A, Winter R, Gratton E. Effect of hydrostatic pressure on water penetration and rotational dynamics in phospholipid-cholesterol bilayers. Biophys J 1997; 72: 1264-1277.##Bharti N, Loona S, Khan M. Proniosomes: A recent advancement in nanotechnology as a drug carrier. Int J Pharm Sci Rev Res 2012; 12: 67-75.##Bragagni M, Mennini N, Ghelardini C, Mura P. Development and characterization of niosomal formulations of doxorubicin aimed at brain targeting. J Pharm Pharm Sci 2012; 15: 184-196.##Burke WJ, Kratochvil CJ. Stereoisomers in psychiatry: the case of escitalopram. Prim Care Companion J Clin Psychiatry 2002; 4: 20.##Charnvanich D, Vardhanabhuti N, Kulvanich P. Effect of cholesterol on the properties of spray-dried lysozyme-loaded liposomal powders. Aaps Pharmscitech 2010; 11: 832-842.##Chen VCH, Hsieh YH, Chen LJ, Hsu TC, Tzang BS. Escitalopram oxalate induces apoptosis in U-87 MG cells and autophagy in GBM 8401 cells. J Cell Mol Med 2018; 22: 1167-1178.##Chubak J, Boudreau DM, Rulyak SJ, Mandelson MT. Colorectal cancer risk in relation to antidepressant medication use. Int J Cancer 2011; 128: 227-232.##Cipriani A, Santilli C, Furukawa TA, Signoretti A, Nakagawa A, McGuire H, et al. Escitalopram versus other antidepressive agents for depression. Cochrane Database of Systematic Reviews 2009.##Dikmen M, Cantürk Z, Öztürk Y. Escitalopram oxalate, a selective serotonin reuptake inhibitor, exhibits cytotoxic and apoptotic effects in glioma C6 cells. Acta Neuropsychiatr 2011; 23: 173-178.##El-Sayed MM, Hussein AK, Sarhan HA, Mansour HF. Flurbiprofen-loaded niosomes-in-gel system improves the ocular bioavailability of flurbiprofen in the aqueous humor. Drug Dev Ind Pharm 2017; 43: 902-910.##Ge X, Wei M, He S, Yuan WEJP. Advances of non-ionic surfactant vesicles (niosomes) and their application in drug delivery. Pharm 2019; 11: 55.##Ghafelehbashi R, Akbarzadeh I, Yaraki MT, Lajevardi A, Fatemizadeh M, Saremi LH. Preparation, physicochemical properties, in vitro evaluation and release behavior of cephalexin-loaded niosomes. Int J Pharm 2019; 569: 118580.##Gil-Ad I, Zolokov A, Lomnitski L, Taler M, Bar M, Luria D, et al. Evaluation of the potential anti-cancer activity of the antidepressant sertraline in human colon cancer cell lines and in colorectal cancer-xenografted mice. Int J Oncol 2008; 33: 277-286.##Hope M, Bally M, Mayer L, Janoff A, Cullis P. Generation of multilamellar and unilamellar phospholipid vesicles. Chem Phys Lipids 1986; 40: 89-107.##Ingallina C, Rinaldi F, Bogni A, Ponti J, Passeri D, Reggente M, et al. Niosomal approach to brain delivery: Development, characterization and in vitro toxicological studies. Int J Pharm 2016; 511: 969-982.##Jang WJ, Jung SK, Vo TTL, Jeong CH. Anticancer activity of paroxetine in human colon cancer cells: Involvement of MET and ERBB3. J Cell Mol Med 2019; 23: 1106-1115.##Kazi KM, Mandal AS, Biswas N, Guha A, Chatterjee S, Behera M, et al. Niosome: a future of targeted drug delivery systems. J Adv Pharm Technol Res 2010; 1: 374.##Kumud U. Development and Evaluation of Bio Nanogels of Selegiline and Escitalopram for Brain Targeting through Ear. 2016.##Lawrence M, Chauhan S, Lawrence S, Barlow D. The formation, characterization and stability of non-ionic surfactant vesicles. STP pharma sci 1996; 6: 49-60.##Llorca P, Brousse G, Schwan R. Escitalopram for treatment of major depressive disorder in adults. L’Encephale 2005; 31: 490-501.##Lockman P, Mumper R, Khan M, Allen D. Nanoparticle technology for drug delivery across the blood-brain barrier. Drug Dev Ind Pharm 2002; 28: 1-13.##Manosroi A, Bauer K. The entrapment of a human insulin-DEAE dextran complex in different compound liposomes. Drug Dev Ind Pharm 1989; 15: 2531-2546.##Manosroi A, Wongtrakul P, Manosroi J, Sakai H, Sugawara F, Yuasa M, et al. Characterization of vesicles prepared with various non-ionic surfactants mixed with cholesterol. Colloids Surf B Biointerfaces 2003; 30: 129-138.##Moazeni E, Gilani K, Sotoudegan F, Pardakhty A, Najafabadi A R, Ghalandari R, et al. Formulation and in vitro evaluation of ciprofloxacin containing niosomes for pulmonary delivery. J Microencapsul 2010; 27: 618-627.##Moghassemi S, Parnian E, Hakamivala A, Darzianiazizi M, Vardanjani M M, Kashanian S, et al. Uptake and transport of insulin across intestinal membrane model using trimethyl chitosan coated insulin niosomes. Mater Sci Eng C 2015; 46: 333-340.##Mokhtar M, Sammour OA, Hammad MA, Megrab NA. Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes. Int J Pharm 2008; 361: 104-111.##Montgomery SA, Loft H, Sánchez C, Reines EH, Papp M. Escitalopram (S-enantiomer of citalopram): Clinical efficacy and onset of action predicted from a rat model. Pharmacol Toxicol 2001; 88: 282-286.##Pardakhty A, Moazeni E, Varshosaz J, Hajhashemi V, Rouholamini Najafabadi A. Pharmacokinetic study of niosome-loaded insulin in diabetic rats. Daru 2011; 19.##Patel R. Anti-proliferative effects of selected antidepressant agents on human metastatic breast cancer cell line, MDA-MB-231. Journal 2013.##Rajput R, Kumar S, Nag P, Singh M. Fabrication and characterization of chitosan based polymeric escitalopram nanoparticles. J App Pharm Sci 2016; 6: 171-177.##Raslan M. Effect of some formulation variables on the entrapment efficiency and in vitro release of ketoprofen from ketoprofen niosomes. J Life Med 2013; 1: 15-22.##Rochdy Haj-Ahmad R, Ali Elkordy A, Shu Chaw C. In vitro characterisation of Span™ 65 niosomal formulations containing proteins. Curr Drug Deliv 2015; 12: 628-639.##Ruckmani K, Sankar V. Formulation and optimization of zidovudine niosomes. Aaps pharmscitech 2010; 11: 1119-1127.##Sadeghi S, Ehsani P, Cohan RA, Sardari S, Akbarzadeh I, Bakhshandeh H, et al. Design and Physicochemical Characterization of Lysozyme Loaded Niosomal Formulations as a New Controlled Delivery System. Pharm Chem J 2020: 1-10.##Sankhyan A, Pawar P. Recent trends in niosome as vesicular drug delivery system. J Appl Pharm Sci 2012; 2: 20-32.##Seras-Cansell M, Ollivon M, Lesieur S. Generation of non-ionic monoalkyl amphiphile-cholesterol vesicles: evidence of membrane impermeability to octyl glucoside. STP pharma sci 1996; 6: 12-20.##Shaker DS, Shaker MA, Hanafy MS. Cellular uptake, cytotoxicity and in-vivo evaluation of Tamoxifen citrate loaded niosomes. Int J Pharm 2015; 493: 285-294.##Tavano L, Muzzalupo RJC, Biointerfaces SB. Multi-functional vesicles for cancer therapy: the Ultimate magic bullet. Colloids Surf B Biointerfaces 2016 1; 147:161-171.##Taylor C, Pollack M, LeBeau R, Simon N. Anxiety disorders: panic, social anxiety, and generalizedanxiety. Massachusetts General Hospital ComprehensiveClinical Psychiatry. 1st ed. Philadelphia, PA: Elsevier Mosby 2008.##Taymouri S, Varshosaz J. Effect of different types of surfactants on the physical properties and stability of carvedilol nano-niosomes. Adv biomed res 2016; 16;5:48.##Uchegbu IF, Vyas SP. Non-ionic surfactant based vesicles (niosomes) in drug delivery. Int J pharma 1998; 172: 33-70.##Waddad AY, Abbad S, Yu F, Munyendo WL, Wang J, Lv H, et al. Formulation, characterization and pharmacokinetics of Morin hydrate niosomes prepared from various non-ionic surfactants. Int J pharma 2013; 456: 446-458.##Weiner AL. Liposomes as carriers for polypeptides. Adv Drug Deliv Rev 1989; 3: 307-341.##Yang H. Nanoparticle-mediated brain-specific drug delivery, imaging, and diagnosis. Pharma res 2010; 27: 1759-1771.##Yoshioka T, Sternberg B, Florence A T. Preparation and properties of vesicles (niosomes) of sorbitan monoesters (Span 20, 40, 60 and 80) and a sorbitan triester (Span 85). Int J pharma 1994; 105: 1-6.##Yuan I, Horng CT, Chen VCH, Chen CH, Chen LJ, Hsu TC, et al. Escitalopram oxalate inhibits proliferation and migration and induces apoptosis in non-small cell lung cancer cells. Oncol Let 2018; 15: 3376-3382.## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>The effect of calcium channels blockade on slow-wave distribution in the electrophysiological model of human gastric wall smooth muscle cells</TitleF>
		<TitleE></TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Introduction: Two of the most important ion channels in the smooth muscle membrane are L-type and T-type calcium channels. L-type calcium channels are responsible for smooth muscle contraction, while T-type calcium channels are involved in cell membrane depolarization.
Methods: In this study, a model consisting of 1200 cells was used to simulate the smooth muscle of the gastric wall. The paper explores the effects of blocking 10%, 50%, 90%, and 100% of L-type and T-type calcium channels on the spatiotemporal wavefront propagation in human gastric wall smooth muscle cells, simulated separately.
Results: The results showed that complete blockage had the most significant effect on the slow-wave. Blockage of the L-type calcium channel led to a reduction of -3.4% and -0.8% in the membrane potential during the spike and plateau phases, respectively. The T-type calcium channel reduced the spike and resting membrane potential by -1.8% and -0.9%, respectively. In addition, the L-type calcium channel exhibited a greater impact on reducing muscle contraction compared to the T-type calcium channel. This suggests that higher blockage of calcium channels led to decreased membrane potential during slow-wave phases and reduced muscle contraction, compared to the physiological state.
Conclusion: Blocking ion channels in electrophysiological models can potentially help control gastrointestinal tract motility disorders and smooth muscle contraction.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>319</FPAGE>
			<TPAGE>330</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2022/07/312022/08/222022/07/32021/09/132022/04/72022/06/302021/08/242022/06/12022/05/22021/12/14
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1400/9/23
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2022/12/32022/11/272022/09/182022/08/272022/09/182022/10/242022/12/32022/12/312022/12/172022/09/18
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1401/6/27
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>Hossein</Name>
				<MidName></MidName>
				<Family>Taghadosi</Family>
				<NameE>Hossein</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Taghadosi</FamilyE>
				<Organizations>
				<Organization>Department of Biomedical Engineering, Science and Research Branch, Islamic Azad University, Tehran, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>h.taghadosi@srbiau.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Farhad</Name>
				<MidName></MidName>
				<Family>Tabatabai Ghomsheh</Family>
				<NameE>Farhad</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Tabatabai Ghomsheh</FamilyE>
				<Organizations>
				<Organization>Pediatric Neurorehabilitation Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>fa.tabatabai@uswr.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Aydin</Name>
				<MidName></MidName>
				<Family>Farajidavar</Family>
				<NameE>Aydin</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Farajidavar</FamilyE>
				<Organizations>
				<Organization>Department of Electrical and Computer Engineering, New York Institute of Technology, Old Westbury, New York, USA</Organization>
				</Organizations>
				<Countries>
				<Country>USA</Country>
				</Countries>
				<EMAILS>
				<Email>afarajid@nyit.edu</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Faezeh</Name>
				<MidName></MidName>
				<Family>Khazaee</Family>
				<NameE>Faezeh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Khazaee</FamilyE>
				<Organizations>
				<Organization>Department of Biomedical Engineering, Science and Research Branch, Islamic Azad University, Tehran, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>faezeh.khazaee@srbiau.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Fatemeh</Name>
				<MidName></MidName>
				<Family>Hoseinpour</Family>
				<NameE>Fatemeh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Hoseinpour</FamilyE>
				<Organizations>
				<Organization>Department of Occupational Therapy, Semnan University of Medical Science, Semnan, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>h.hoseinpour_ot@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Stomach</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Smooth Muscle Cell</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Slow-wave</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Calcium Channel Blockers</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Electrophysiology</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>Annaházi A, Róka R, Rosztóczy A, Wittmann T. Role of antispasmodics in the treatment of irritable bowel syndrome. World J Gastoentrol: WJG 2014; 20: 6031.##Bayginov O, Bonev A, Boev K, Papasova M. Electromechanical coupling in cat stomach smooth muscle in Ca2+-free EGTA-containing solutions. Acta Physiol Pharmacol Bulg 1989; 15: 31-38.##Beyder A, Farrugia G. Targeting ion channels for the treatment of gastrointestinal motility disorders. Therap Adv Gastroenterol 2012; 5: 5-21.##Blanc O. A computer model of human atrial arrhythmia (PhD thesis). Lausanne, Ecole Polytechnique (EPFL) 2002.##Brandstaeter S, Gizzi A, Fuchs SL, Gebauer AM, Aydin RC, Cyron CJ. Computational model of gastric motility with active-strain electromechanics. ZAMM- Z Angew Math Mech/Zeitschrift für Angewandte Mathematik und Mechanik 2018; 98: 2177-2197.##Carson DA, O’Grady G, Du P, Gharibans AA, Andrews CN. Body surface mapping of the stomach: New directions for clinically evaluating gastric electrical activity. Neurogastroenterol Motil 2021; 33: e14048.##Chul Kim Y, Don Koh S, Sanders KM. Voltage-dependent inward currents of interstitial cells of Cajal from murine colon and small intestine. J physiol 2002; 541: 797-810.##Corrias A, Buist M L. Quantitative cellular description of gastric slow wave activity. American Journal of Physiology-Gastrointestinal and Liver Physiology 2008; 294: G989-G995.##Corrias A, Buist ML. A quantitative model of gastric smooth muscle cellular activation. Ann Biomed Eng 2007; 35: 1595-1607.##Du P, Calder S, Angeli TR, Sathar S, Paskaranandavadivel N, O’Grady G, et al. Progress in mathematical modeling of gastrointestinal slow wave abnormalities. Front Physiol 2018; 8: 1136.##Du P, Liu JY, Sukasem A, Qian A, Calder S, Rudd JA. Recent progress in electrophysiology and motility mapping of the gastrointestinal tract using multi-channel devices. J R Soc N Z 2020; 50: 316-330.##Evans ED, Mangel AW. Depolarization-stimulated contractility of gastrointestinal smooth muscle in calcium-free solution: a review. ISRN gastroenterol 2010; 2011.##Farajidavar A. Bioelectronics for mapping gut activity. Brain Res 2018; 1693: 169-173.##Franck H, Kong I, Shuttleworth C, Sanders K. Rebound excitation and alternating slow wave patterns depend upon eicosanoid production in canine proximal colon. J physiol 1999; 520: 885.##Hedley P L, Jørgensen P, Schlamowitz S, Wangari R, Moolman-Smook J, Brink P A, et al. The genetic basis of long QT and short QT syndromes: a mutation update. Hum Mutat 2009; 30: 1486-1511.##Hocke M, Schöne U, Richert H, Görnert P, Keller J, Layer P, et al. Every slow-wave impulse is associated with motor activity of the human stomach. Am J Physiol Gastrointest Liver Physiol 2009; 296: 709-716.##Hodgkin AL, Huxley AF. A quantitative description of membrane current and its application to conduction and excitation in nerve. J physiol 1952; 117: 500.##Hotta A, Okada N, Suzuki H. Mibefradil-sensitive component involved in the plateau potential in submucosal interstitial cells of the murine proximal colon. Biochem Biophys Res Commun 2007; 353: 170-176.##Huizinga J, Farraway L, Den Hertog A. Generation of slow-wave-type action potentials in canine colon smooth muscle involves a non-L-type Ca2+ conductance. The J Physiol 1991; 442: 15-29.##Huizinga JD. II. Gastric motility: lessons from mutant mice on slow waves and innervation. Am J Physiol Gastrointest Liver Physiol 2001; 281: 1129-1134.##Jung KT, Park H, Kim J-H, Shin D-J, Joung B Y, Lee M-H, et al. The relationship between gastric myoelectric activity and SCN5A mutation suggesting sodium channelopathy in patients with brugada syndrome and functional dyspepsia-a pilot study. J Neurogastroenterol Motil 2012; 18: 58.##Kushner J, Ferrer X, Marx SO. Roles and Regulation of Voltage-gated Calcium Channels in Arrhythmias. J Innov Card Rhythm Manag 2019; 10: 3874.##Lees-Green R, Du P, O’Grady G, Beyder A, Farrugia G, Pullan A. Biophysically based modeling of the interstitial cells of Cajal: current status and future perspectives. Front Physiol 2011; 2: 29.##Lin Z, Chen J. Developments in gastrointestinal electrical stimulation. Critical Reviews™ in Biomedical Engineering 2017; 45.##Miedema BW, Sarr M, Kelly K. Pacing the human stomach. Surgery 1992; 111: 143-150.##Nasu T, Murase H, Shibata H. Manganese ions penetrate via L-type Ca2+ channels and induce contraction in high-K+ medium in ileal longitudinal muscle of guinea-pig. Gen Pharmacol 1995; 26: 381-386.##O’Grady G, Du P, Cheng LK, Egbuji JU, Lammers WJ, Windsor JA, et al. Origin and propagation of human gastric slow-wave activity defined by high-resolution mapping. Am J Physiol Gastrointest Liver Physiol 2010; 299: G585-G592.##Poh Y C, Corrias A, Cheng N, Buist M L. A quantitative model of human jejunal smooth muscle cell electrophysiology. PLoS One 2012; 7: e42385.##Radulovic M, Anand P, Korsten MA, Gong B. Targeting ion channels: An important therapeutic implication in gastrointestinal dysmotility in patients with spinal cord injury. J Neurogastroenterol Motil 2015; 21: 494.##Rhee PL, Lee JY, Son HJ, Kim JJ, Rhee JC, Kim S, et al. Analysis of pacemaker activity in the human stomach. J physiol 2011; 589: 6105-6118.##Rychter J, Espín F, Gallego D, Vergara P, Jiménez M, Clavé P. Colonic smooth muscle cells and colonic motility patterns as a target for irritable bowel syndrome therapy: mechanisms of action of otilonium bromide. Therap Adv Gastroenterol 2014; 7: 156-166.##Sanders KM, Koh SD, Ward SM. Organization and electrophysiology of interstitial cells of Cajal and smooth muscle cells in the gastrointestinal tract. Physiology of the gastrointestinal tract: Elsevier, 2006: 533-576.##Seth S, Seth S. Calcium channels and calcium channel blockers. Indian J Physiol Pharmacol 1991; 35: 217-231.##Sha W, Pasricha PJ, Chen JD. Rhythmic and spatial abnormalities of gastric slow waves in patients with functional dyspepsia. J Clin Gastroenterol 2009; 43: 123-129.##Shinohara Y, Kosaka I. Contribution of intracellular stored calcium to contractile activation in contractures of stomach circular muscle of Bufo vulgaris formosus. Japan J physiol 1984; 34: 443-455.##Suzuki H, Hirst G. Regenerative potentials evoked in circular smooth muscle of the antral region of guinea-pig stomach. J physiol 1999; 517: 563-573.##Taghadosi H, Ghomsheh FT, Dabanloo NJ, Farajidavar A. Electrophysiological modeling of the effect of potassium channel blockers on the distribution of stimulation wave in the human gastric wall cells. J Biomech 2021; 127: 110662.##Taghadosi H, Tabatabai Ghomsheh F, Farajidavar A, Khazaee F, Hoseinpour F, Beshkooh Z. Electromechanical modeling and simulation of the physiological state of human gastric wall smooth muscle cells. Comput Sci Eng 2022a; 2: 9-19.##Taghadosi H, Tabatabai Ghomsheh F, Jafarnia Dabanloo N, Farajidavar A. The Role of Potassium Channel Gates in the Electrophysiology of the Human Gastric Smooth Muscle Cell. 2022b; In Press: e119450.##To KH, Gui P, Li M, Zawieja SD, Castorena-Gonzalez JA, Davis MJ. T-type, but not L-type, voltage-gated calcium channels are dispensable for lymphatic pacemaking and spontaneous contractions. Sci Rep 2020; 10: 1-24.##Van Helden DF, Laver DR, Holdsworth J, Imtiaz M S. Generation and propagation of gastric slow waves. Clin Exp Pharmacol Physiol 2010; 37: 516-524.##Ward SM, Dixon RE, De Faoite A, Sanders KM. Voltage-dependent calcium entry underlies propagation of slow waves in canine gastric antrum. J physiol 2004; 561: 793-810.##Wegener JW, Schulla V, Koller A, Klugbauer N, Feil R, Hofmann F. Control of intestinal motility by the Ca (v) 1.2 L-type calcium channel in mice. FASEB J 2006; 20: 1260-1262.##Whittaker DG, Clerx M, Lei CL, Christini DJ, Mirams GR. Calibration of ionic and cellular cardiac electrophysiology models. Wiley Interdiscip Rev Syst Biol Med 2020; 12: e1482.##Yeoh JW, Corrias A, Buist ML. Modelling human colonic smooth muscle cell electrophysiology. Cell Mol Bioeng 2017; 10: 186-197.##Yoneda S, Takano H, Takaki M, Suzuki H. Properties of spontaneously active cells distributed in the submucosal layer of mouse proximal colon. The Journal of physiology 2002; 542: 887-897.##Zhou H, Kong D-H, Pan Q-W, Wang H-H. Sources of calcium in agonist-induced contraction of rat distal colon smooth muscle in vitro. World J Gastoentrol 2008; 14: 1077.##Zhou J, Jameson C, Ho V. High-Amplitude Gastric Contractions following Laparoscopic Sleeve Gastrectomy. Case rep surg 2019; 2019.## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>

</ARTICLES>

</JOURNAL>
</XML>
